Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
ABHD18	"C4orf29, FLJ21106"	ENSG00000164074	"Abhydrolase domain containing 18"	Q0P651	4	127965306-128039927	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050168, HPA051676"	Approved		Approved	"Nuclear membrane"	"Intracellular and membrane"	NA	NA			"Nuclear membrane"		"HPA050168: AB_2681040, HPA051676: AB_2681571"	"unprognostic (1.91e-1)"	"unprognostic (8.66e-2)"	"prognostic favorable (5.35e-4)"	"unprognostic (1.74e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.60e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.76e-3)"	"unprognostic (2.17e-3)"	"unprognostic (1.49e-2)"	"unprognostic (2.59e-1)"	"unprognostic (7.32e-2)"	"prognostic favorable (9.13e-4)"	7.6	8.2	7.4	13.2	10.5	9.9	8.4	14.1	7.9	7.1	13.6	8.6	8.3	13.7	9.2	9.8	7.2	7.8	9.6	25.1	7.0	7.5	9.1	15.7	9.2	12.0	7.2	5.2	10.8	24.5	8.0	16.3	7.0	8.4	6.8	10.2	7.5	8.9	11.1	18.7	10.6	19.0	9.8	9.7	10.0	8.2	4.0	8.1	18.2	9.2	10.9	10.5	8.4	7.5	10.2	8.8	14.2	7.1	5.2	8.8	3.5	3.5	2.9	3.7	4.5	2.9	4.1	5.5	3.6	2.9	3.2	4.2	6.8	6.3	9.7	5.9	1.4	2.9	3.5	7.7	4.2	3.5	8.0	2.5	7.1	4.7	5.4	4.1	12.0	9.0	3.4	2.9	3.4	2.2	3.8	5.6	7.4	11.7	7.1	2.9	6.4	15.7	5.7	3.8	7.6	2.9	8.8	1.3	6.2	4.7	3.7	8.5	3.1	3.4	6.1	3.7	5.5	5.2	5.0	4.8	2.0	2.7	5.2	3.4	12.7	12.6	11.5	3.5	13.0	3.3	11.1	7.1	9.5	6.3	5.9	4.6	6.8	8.0	7.3	5.7	10.2	8.7	8.8	14.2	5.2	4.2	8.8	8.2	3.5	7.4	10.5	14.1	7.9	7.0	7.5	7.2	5.2	8.4	8.1	6.0	12.5	5.3	8.0	0.0	13.0	0.0	5.1	6.7	10.3	7.0	19.6	4.5	0.0	4.0	2.8	3.0	8.5	0.0	6.4	3.9	2.1	10.7	1.1	20.2	6.7	17.5	5.8	9.2	17.0	0.9	5.8	10.9	0.0	3.6	11.7	6.5	6.5	3.5	5.3	6.2	17.4	12.9	0.0	5.5	3.6	0.0	7.7	5.0	10.1	7.8
AC010319.2		ENSG00000269035			19	17436611-17460804	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	32	"retina: 41.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 1.3;HHSteC: 1.0;THP-1: 1.2"									HPA041580	Approved		Uncertain	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA041580: AB_10795700"																		0.9	0.2	0.4	0.1	0.5	0.1	0.3	0.1	0.5	0.1	0.4	0.1	0.0	0.1	0.1	0.1	0.1	0.5	0.1	0.3	0.5	0.4	0.1	0.1	0.3	0.1	0.2	0.0	0.7	0.1	0.1	0.3	0.1	1.2	0.1	0.1	41.6	0.1	0.1	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.1	0.5	0.5	0.4	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AHCTF1	ELYS	ENSG00000153207	"AT-hook containing transcription factor 1"	Q8WYP5	1	246839098-246931978	"Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, mRNA transport, Protein transport, Translocation, Transport"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Spermatocytes: 114.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 8.4"	"Group enriched"	"Detected in many"	5	"B-cells: 5.0;granulocytes: 8.4;T-cells: 2.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031658	Uncertain		Supported	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA031658: AB_10601968"	"unprognostic (3.10e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.20e-1)"	"unprognostic (6.11e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.12e-2)"	"unprognostic (8.50e-2)"	"unprognostic (2.06e-3)"	"unprognostic (2.53e-2)"	"unprognostic (7.12e-2)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (3.49e-8)"	"unprognostic (7.65e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.91e-2)"	"unprognostic (8.52e-2)"	20.2	13.7	10.4	11.0	17.4	17.3	14.3	23.3	12.9	12.2	12.6	7.5	10.3	8.3	13.8	8.2	10.7	14.7	8.9	14.9	10.1	6.8	13.4	13.1	9.7	9.5	11.6	8.3	23.3	12.3	19.2	17.6	10.7	10.9	10.1	8.1	7.4	10.7	11.5	15.6	11.3	10.3	10.1	11.4	12.5	12.7	33.9	11.3	17.9	15.3	8.8	9.7	14.5	20.9	5.0	1.1	8.4	0.9	0.7	2.9	0.7	23.9	12.2	10.8	9.5	10.7	10.7	22.9	17.4	8.5	12.7	10.5	11.9	9.1	23.7	19.0	9.0	7.5	20.7	17.2	8.9	21.5	16.8	7.2	15.0	13.3	10.4	8.0	21.7	11.8	10.2	7.9	16.4	16.8	5.9	9.2	8.9	41.6	11.6	12.1	5.5	16.1	9.8	25.1	14.4	13.3	19.8	17.5	18.4	7.8	12.1	13.6	19.8	22.8	8.7	9.3	8.3	11.1	13.5	12.0	13.1	15.1	18.4	32.7	21.1	29.5	26.5	10.6	13.8	12.7	0.7	0.6	1.7	1.7	0.3	1.3	5.0	1.9	1.6	0.8	1.3	2.9	1.5	8.4	0.7	0.9	1.1	2.9	0.7	10.4	17.4	23.3	12.9	10.1	6.8	11.6	8.3	10.9	11.3	32.8	25.4	17.3	13.4	26.7	19.8	17.1	7.6	21.4	27.3	5.2	7.9	12.0	3.3	11.2	54.5	16.3	12.2	0.0	10.5	9.1	14.6	17.6	11.5	12.5	8.0	17.5	20.7	19.0	15.5	17.5	33.4	16.8	3.3	11.8	12.5	8.9	13.9	10.5	36.7	7.6	15.4	32.3	23.7	114.9	37.5	26.8	11.3	13.8	11.2	22.6
AMPD3		ENSG00000133805	"Adenosine monophosphate deaminase 3"	Q01432	11	10308313-10507579	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 39.2;skeletal muscle: 61.0"	"Cell type enhanced"	"Detected in many"	7	"Erythroid cells: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 24.7;CAPAN-2: 19.3;HMC-1: 20.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038662, HPA047408"	Uncertain		Approved	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA038662: AB_2676136, HPA047408: AB_2680034"	"unprognostic (2.24e-1)"	"unprognostic (3.88e-3)"	"unprognostic (1.44e-2)"	"prognostic favorable (2.37e-4)"	"unprognostic (1.89e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.91e-3)"	"unprognostic (1.25e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.84e-2)"	"unprognostic (4.68e-1)"	"unprognostic (3.06e-2)"	"unprognostic (7.07e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.98e-1)"	"unprognostic (2.12e-2)"	2.9	13.7	5.3	13.8	14.0	39.2	2.3	2.3	7.8	3.3	3.4	19.6	0.7	4.7	3.1	4.2	5.2	8.0	4.6	2.1	7.4	7.1	4.2	1.5	4.5	12.7	15.2	5.7	2.3	2.5	24.9	14.5	3.7	11.2	5.5	4.9	4.3	4.7	2.8	61.0	10.8	5.0	3.1	12.8	8.3	4.6	1.4	12.6	14.8	2.7	7.6	14.2	6.1	5.1	7.6	3.9	17.0	6.0	3.3	5.3	2.3	7.6	1.1	0.3	0.1	4.1	2.9	0.4	6.9	24.7	1.7	1.8	3.8	19.3	2.8	0.7	3.1	6.8	4.8	0.1	6.5	5.1	6.9	0.2	6.8	1.0	0.5	1.4	9.2	20.5	10.8	10.2	3.4	4.4	4.3	0.7	4.6	10.3	3.0	5.6	0.2	5.4	12.1	0.9	0.6	6.8	2.0	9.0	9.9	0.3	6.5	2.9	1.5	1.5	0.2	0.4	0.6	0.2	3.1	1.9	7.9	0.1	5.4	0.2	2.7	1.5	3.0	9.0	9.2	0.2	6.6	6.0	17.0	2.3	3.8	5.3	7.6	3.3	2.5	3.9	5.8	3.7	2.5	8.3	3.3	1.6	2.5	1.9	2.3	5.3	14.0	2.3	7.8	7.4	7.1	15.2	5.7	11.2	12.6	0.0	4.6	5.2	8.9	11.1	20.7	5.6	7.6	12.0	7.9	14.0	2.0	0.7	14.9	2.4	7.0	1.0	1.7	46.7	1.4	1.1	1.4	17.1	11.5	0.6	13.4	0.0	9.8	1.8	14.3	14.2	0.9	9.1	3.3	13.6	3.2	6.8	3.9	2.9	0.0	1.0	1.3	0.0	1.7	0.2	0.5	10.9	1.0	2.9	2.2	16.1
ANXA5	"ANX5, ENX2"	ENSG00000164111	"Annexin A5"	P08758	4	121667955-121697113	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Blood coagulation, Hemostasis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cytotrophoblasts: 989.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003677, HPA035330"	Approved		Approved	"Nuclear membrane"		NA	NA		6100000	"Nuclear membrane"		"CAB003677: AB_425305, HPA035330: AB_2674574"	"unprognostic (1.22e-1)"	"unprognostic (1.03e-2)"	"unprognostic (9.70e-2)"	"prognostic favorable (3.64e-4)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (3.01e-5)"	"prognostic unfavorable (1.64e-5)"	"unprognostic (7.33e-3)"	"unprognostic (3.09e-1)"	"unprognostic (6.04e-2)"	"unprognostic (6.49e-3)"	"unprognostic (4.54e-1)"	"prognostic unfavorable (9.29e-7)"	"prognostic unfavorable (7.19e-4)"	"unprognostic (1.02e-1)"	"unprognostic (1.53e-2)"	"prognostic unfavorable (1.26e-4)"	130.1	65.6	24.6	43.2	26.1	15.3	151.3	10.0	17.9	85.9	35.6	33.8	45.1	17.5	64.4	45.9	42.8	42.4	54.7	46.8	22.5	25.1	62.2	73.1	68.0	49.3	37.8	16.4	62.6	52.1	25.7	55.3	135.8	40.8	57.1	29.8	56.1	83.7	49.8	23.1	28.0	30.1	68.3	51.5	67.9	39.4	33.3	27.8	15.9	61.8	32.5	31.2	57.3	69.8	13.9	80.0	37.2	87.3	4.8	29.9	64.7	30.9	23.0	31.3	17.3	151.1	115.4	34.2	110.1	98.2	57.1	51.2	16.7	13.5	2.3	19.9	151.0	40.0	11.0	19.9	48.7	53.7	22.1	11.4	6.9	21.7	45.4	86.6	14.9	12.0	66.5	23.7	48.6	48.0	65.3	75.3	1.6	6.8	18.7	144.2	20.5	15.1	5.1	16.1	28.0	48.2	0.5	71.7	4.7	95.9	4.6	8.0	9.7	39.7	15.5	100.2	64.9	13.6	17.9	55.6	91.0	44.5	65.0	32.7	16.8	20.3	5.2	58.2	8.1	106.9	9.2	74.0	37.2	11.9	87.3	15.5	13.9	18.2	14.8	80.0	8.8	6.1	8.8	17.1	4.8	79.7	9.7	29.9	64.7	24.6	26.1	10.0	17.9	22.5	25.1	37.8	16.4	40.8	27.8	226.3	227.0	73.7	202.4	177.1	4.9	75.9	209.0	279.7	232.0	125.6	23.6	989.9	252.0	588.9	12.3	263.9	14.2	0.0	297.2	883.6	492.7	311.2	142.3	46.9	681.5	12.7	46.7	191.5	406.3	27.8	351.8	564.0	334.0	369.7	81.0	152.9	380.8	32.0	344.4	128.7	28.3	291.1	342.1	9.5	14.1	123.1	954.0	91.3	35.2	131.9
C5orf22	FLJ11193	ENSG00000082213	"Chromosome 5 open reading frame 22"	Q49AR2	5	31532266-31555058	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 17.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043062	Approved		Approved	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA043062: AB_10795766"	"unprognostic (2.58e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.91e-1)"	"unprognostic (8.73e-2)"	"prognostic unfavorable (6.55e-4)"	"unprognostic (1.65e-1)"	"unprognostic (7.30e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.86e-3)"	"unprognostic (1.21e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.50e-1)"	8.8	9.3	8.6	7.7	16.8	7.4	9.5	12.5	24.1	9.5	9.8	9.0	6.9	6.4	10.8	5.8	10.1	9.2	8.5	15.1	8.9	10.8	11.2	10.0	9.5	10.1	8.3	10.7	6.8	15.0	14.9	8.1	10.9	14.8	9.2	11.5	8.7	10.1	8.4	29.0	8.4	8.4	12.2	7.9	7.6	9.5	5.3	5.9	11.9	9.8	7.2	12.4	11.4	7.1	2.7	2.7	17.3	5.3	3.1	3.9	1.8	5.1	4.4	9.8	13.8	7.9	6.2	11.2	7.9	6.7	10.1	7.9	5.2	5.6	4.2	11.9	7.8	8.7	3.9	12.4	7.2	10.9	6.3	6.1	8.4	14.3	6.7	11.7	12.4	29.4	8.9	9.2	6.9	10.9	3.9	8.3	6.0	11.3	7.3	11.4	5.5	6.3	3.1	5.7	4.9	5.7	5.8	16.8	5.7	7.4	8.6	6.6	9.8	25.5	11.0	17.9	6.5	8.4	8.9	7.1	7.5	8.8	9.2	8.6	4.3	9.5	8.0	4.3	22.4	10.9	17.3	2.5	1.9	3.0	2.9	2.9	2.7	3.6	2.8	2.7	2.7	3.9	3.6	1.4	3.1	5.3	1.2	2.4	1.8	8.6	16.8	12.5	24.1	8.9	10.8	8.3	10.7	14.8	5.9	3.0	4.0	6.8	2.6	3.9	3.7	21.8	5.1	9.4	5.7	12.2	0.0	4.8	1.7	3.8	2.1	4.5	6.4	0.0	5.3	5.1	3.4	4.2	7.0	9.0	5.6	6.4	6.4	7.4	11.3	1.6	4.4	3.8	8.5	8.2	8.2	4.9	5.5	5.8	3.2	6.1	4.5	6.5	3.3	3.9	7.0	3.4	4.5	7.2	6.6	4.1
C6orf141	MGC46457	ENSG00000197261	"Chromosome 6 open reading frame 141"	Q5SZD1	6	49550646-49561907	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.6;gallbladder: 18.9"	"Cell type enhanced"	"Detected in many"	16	"Basal keratinocytes: 36.7;Ductal cells: 32.6;Intestinal endocrine cells: 102.0;Suprabasal keratinocytes: 31.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	10	"basal ganglia: 30.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 8.0;HaCaT: 8.8;HeLa: 7.0;hTCEpi: 6.9;PC-3: 12.0;T-47d: 7.5"									HPA036199	Uncertain		Approved	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA036199: AB_2675002"	"prognostic favorable (3.92e-6)"	"unprognostic (1.58e-1)"	"unprognostic (9.87e-2)"	"prognostic favorable (1.15e-4)"	"unprognostic (4.95e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.39e-3)"	"unprognostic (8.13e-2)"	"unprognostic (7.02e-2)"	"unprognostic (2.85e-2)"	"unprognostic (6.37e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.89e-8)"	"unprognostic (2.33e-2)"	"unprognostic (5.81e-1)"	"unprognostic (3.77e-1)"	"unprognostic (4.43e-1)"	4.7	0.2	1.0	3.0	30.6	0.0	4.9	3.1	1.8	3.7	2.1	0.3	4.4	10.5	4.4	3.6	2.9	1.9	18.9	0.4	0.3	0.4	0.3	1.1	0.6	0.6	0.5	0.1	0.5	3.3	0.0	2.0	0.2	2.8	1.1	1.4	0.0	2.2	0.9	1.2	4.6	1.4	1.4	0.3	0.1	9.1	3.1	2.9	0.0	1.1	0.4	0.8	1.7	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	3.1	0.0	0.0	0.0	0.0	1.6	0.8	0.9	0.0	0.0	0.2	3.3	0.0	0.5	1.5	8.0	8.8	1.0	2.3	0.0	0.0	5.6	0.0	7.0	0.0	0.3	0.0	0.0	0.3	6.9	0.0	5.0	2.7	1.7	0.0	0.1	0.0	0.0	0.1	0.0	0.0	3.3	1.2	12.0	0.0	0.0	0.0	1.6	5.2	0.2	0.0	2.2	0.0	0.0	0.4	7.5	0.0	2.7	0.4	0.0	0.0	5.7	0.0	0.0	0.0	5.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	30.6	3.1	1.3	0.3	0.4	0.5	0.1	2.8	2.9	0.0	1.9	0.0	22.6	36.7	0.0	2.0	7.6	5.3	12.5	0.0	0.0	2.9	0.0	32.6	0.2	8.8	2.0	0.0	8.1	15.4	0.9	2.7	0.0	0.0	0.8	0.0	102.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.2	0.0	7.8	7.0	0.4	0.0	0.0	0.0	0.9	0.5	0.5	31.5	1.7	0.0	1.7	13.2
CACNA1D	"CACH3, CACN4, CACNL1A2, Cav1.3, CCHL1A2"	ENSG00000157388	"Calcium voltage-gated channel subunit alpha1 D"	Q01668	3	53328963-53813733	"Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Cancer-related genes, Deafness, Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 2: 45.9;Cone photoreceptor cells: 33.4;Intestinal endocrine cells: 57.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	9	"basophil: 7.2"	"Lineage enriched"	"Detected in single"	20	"granulocytes: 7.2"	"Cell line enhanced"	"Detected in some"		"HMC-1: 14.4;RPMI-8226: 33.6;SK-BR-3: 6.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA020215	Uncertain		Approved	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA020215: AB_1845860"	"unprognostic (5.85e-2)"	"unprognostic (4.90e-3)"	"unprognostic (5.09e-2)"	"unprognostic (2.24e-2)"	"unprognostic (7.55e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.95e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.90e-3)"	"unprognostic (1.53e-1)"	"prognostic favorable (8.34e-8)"	"unprognostic (1.14e-1)"	"unprognostic (3.05e-2)"	"unprognostic (8.09e-3)"	"unprognostic (6.70e-3)"	0.6	13.4	10.0	0.8	12.6	1.4	3.6	12.2	16.5	11.2	2.8	3.7	0.1	3.3	6.8	13.2	1.2	14.9	6.2	1.8	5.3	3.5	4.2	3.0	9.0	0.5	2.5	9.6	1.2	5.3	3.0	13.6	1.4	8.7	5.7	3.1	10.1	1.1	3.5	0.6	1.5	4.2	1.7	2.2	4.4	1.8	3.0	1.6	0.0	5.2	0.0	0.6	2.3	0.6	0.1	0.3	7.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	1.6	1.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.5	0.0	0.0	0.1	33.6	0.3	2.2	3.1	1.3	0.2	6.3	0.7	0.0	1.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	7.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	10.0	12.6	12.2	16.5	5.3	3.5	2.5	9.6	8.7	1.6	3.0	45.9	0.0	0.6	0.8	23.0	1.2	12.7	14.7	14.8	1.8	33.4	0.6	0.0	5.5	3.6	0.5	3.3	0.0	2.0	0.1	1.0	2.6	11.6	2.4	0.2	7.9	57.1	0.0	1.0	4.9	4.0	0.3	5.0	0.0	2.7	2.5	2.6	3.5	25.5	1.6	13.0	0.0	2.8	1.1	2.5	0.9	0.2	1.3	4.5	0.6
CASC3	"BTZ, MLN51"	ENSG00000108349	"Cancer susceptibility 3"	O15234	17	40140318-40172183	"Cancer-related genes, Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, Stress response, Translation regulation, Transport"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024592, HPA050262"	Approved		Approved	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA024592: AB_1846034, HPA050262: AB_2681067"	"unprognostic (3.76e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.48e-3)"	"unprognostic (3.40e-3)"	"unprognostic (3.38e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.29e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.48e-2)"	27.4	21.0	37.8	20.4	34.8	22.6	26.8	30.0	36.5	30.1	27.3	40.7	19.3	16.4	35.9	26.8	22.2	35.1	21.7	17.8	36.6	32.7	21.6	14.7	23.2	21.8	39.9	27.7	42.1	22.7	31.8	32.6	21.4	29.4	27.4	23.4	25.7	22.5	36.6	50.9	23.0	19.6	35.0	40.7	23.2	22.7	59.7	31.0	19.6	29.4	18.1	25.5	34.1	29.7	6.5	7.2	26.1	11.5	6.8	9.2	5.6	13.5	13.9	17.9	20.1	14.5	15.3	11.5	13.8	12.3	19.0	16.5	15.1	11.8	25.4	22.1	17.3	15.6	24.4	21.8	14.6	26.0	17.3	19.3	18.3	17.3	15.1	13.2	22.3	12.4	15.8	13.5	18.5	29.1	14.7	23.5	14.0	19.6	19.0	15.5	7.8	32.7	12.6	14.1	11.9	8.5	20.5	23.9	26.0	9.8	11.9	28.1	16.1	20.5	74.3	18.1	29.6	24.4	17.6	15.6	16.6	17.3	15.6	21.7	18.2	16.8	25.7	15.8	12.2	17.9	5.8	5.9	8.6	9.2	8.0	8.3	6.5	6.9	8.3	7.2	6.5	7.9	7.4	26.1	6.8	11.5	3.9	6.4	5.6	37.8	34.8	30.0	36.5	36.6	32.7	39.9	27.7	29.4	31.0	17.9	30.8	20.6	20.1	17.5	38.5	23.6	17.8	29.4	45.5	22.7	21.6	17.0	18.3	15.8	11.3	31.6	14.4	0.0	20.7	17.2	23.3	22.2	15.1	19.7	14.8	28.6	30.0	17.2	20.4	18.4	33.4	25.7	33.7	16.2	19.3	20.8	18.6	14.4	28.0	14.3	40.4	12.9	35.0	52.8	63.8	17.3	22.7	21.7	18.8	22.6
CCDC71	FLJ12800	ENSG00000177352	"Coiled-coil domain containing 71"	Q8IV32	3	49162535-49166321	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047547	Uncertain		Approved	"Nuclear membrane"		No	No			"Nuclear membrane"		"HPA047547: AB_2680083"	"unprognostic (1.06e-2)"	"unprognostic (6.02e-2)"	"unprognostic (3.43e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.68e-2)"	"unprognostic (6.71e-3)"	"unprognostic (7.20e-3)"	"unprognostic (2.16e-1)"	"unprognostic (5.77e-2)"	"unprognostic (9.03e-3)"	"unprognostic (7.20e-2)"	"prognostic favorable (9.65e-9)"	"unprognostic (3.53e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.00e-2)"	"unprognostic (7.14e-2)"	15.5	20.2	7.9	11.2	14.4	7.9	18.0	10.8	19.2	17.6	12.3	15.7	14.7	10.1	19.9	17.3	17.4	21.3	17.5	14.8	8.9	8.5	16.2	20.3	13.7	15.2	9.6	9.9	24.1	12.3	12.2	13.1	18.7	10.6	15.3	9.6	16.3	15.8	15.7	17.2	15.8	16.3	12.8	7.3	20.4	13.2	18.1	8.8	33.2	21.5	12.1	19.4	18.3	14.9	3.2	1.9	1.9	3.5	7.8	3.2	1.3	7.9	11.0	12.9	12.3	14.8	10.9	12.4	9.9	14.4	17.4	15.4	11.3	13.0	7.1	8.7	16.9	14.0	8.5	12.7	26.5	6.2	15.8	9.2	14.5	14.3	11.3	17.6	11.6	11.0	18.3	20.9	20.6	15.9	13.0	17.0	17.5	14.5	3.1	13.8	17.1	19.9	7.1	19.9	12.0	11.9	7.3	7.1	6.6	16.4	15.5	6.6	14.2	10.1	10.8	11.8	10.9	14.3	19.4	11.1	12.3	13.1	12.1	12.8	11.7	5.0	9.8	8.9	11.0	13.6	0.0	2.0	0.8	2.0	3.5	3.2	1.2	1.7	2.5	1.9	3.2	2.7	1.7	1.9	7.8	2.6	0.7	1.9	1.3	7.9	14.4	10.8	19.2	8.9	8.5	9.6	9.9	10.6	8.8	6.0	1.0	4.4	10.6	2.4	1.2	1.1	7.6	2.7	0.0	7.0	0.0	19.5	21.6	16.8	6.7	6.3	6.3	0.0	10.3	15.3	6.0	8.9	2.3	8.7	17.4	0.0	8.1	19.0	3.7	8.2	10.9	5.6	5.0	9.0	8.3	4.5	13.7	8.6	12.7	11.9	1.3	12.9	5.2	9.1	15.6	2.4	18.8	2.9	9.7	9.9
CCDC77	MGC13183	ENSG00000120647	"Coiled-coil domain containing 77"	Q9BR77	12	389273-442645	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 19.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038854	Approved		Approved	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA038854: AB_10673121"	"unprognostic (3.25e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.76e-3)"	"unprognostic (7.26e-3)"	"unprognostic (2.34e-1)"	"prognostic unfavorable (8.11e-7)"	"unprognostic (2.54e-2)"	"unprognostic (3.41e-3)"	"unprognostic (2.89e-1)"	"unprognostic (3.82e-1)"	"unprognostic (2.62e-1)"	"unprognostic (4.11e-3)"	"unprognostic (1.27e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.19e-2)"	"unprognostic (4.41e-3)"	7.5	9.8	9.7	9.9	19.2	7.1	7.8	13.8	12.3	6.3	7.0	13.2	3.2	7.9	8.7	5.4	7.8	6.7	5.4	5.1	8.6	6.2	6.6	5.9	6.7	10.6	11.2	8.6	9.3	5.6	5.3	9.4	6.1	10.4	6.4	8.3	6.1	5.6	4.8	8.2	8.8	6.2	6.0	12.0	8.9	5.5	20.2	12.5	16.2	7.0	4.5	10.1	6.1	6.5	11.4	8.0	5.9	10.8	8.6	8.3	4.4	4.8	6.5	14.4	9.5	4.8	4.3	14.9	12.6	5.8	11.8	19.1	6.6	8.6	11.5	3.0	4.8	6.8	6.8	10.2	3.6	12.7	25.2	10.1	13.1	12.6	8.6	2.8	10.7	6.6	3.3	2.2	11.0	6.9	7.2	7.8	11.3	10.7	12.2	12.0	2.8	10.3	7.5	28.6	6.7	4.8	11.9	26.2	7.2	4.4	3.6	4.1	10.7	12.3	4.7	6.2	22.5	3.8	8.0	7.4	5.9	11.6	10.3	14.2	3.4	6.6	14.6	8.1	10.7	10.2	3.8	7.0	5.9	7.7	10.1	8.0	9.2	7.1	8.3	7.4	11.4	5.1	7.4	5.6	8.6	10.8	8.0	5.0	4.4	9.7	19.2	13.8	12.3	8.6	6.2	11.2	8.6	10.4	12.5	0.0	3.8	6.9	3.3	3.7	2.7	3.4	2.5	5.3	5.7	3.5	5.9	5.1	6.6	2.5	19.3	2.9	2.1	0.0	1.7	6.4	3.5	2.1	6.9	1.8	4.8	1.6	2.4	3.7	7.0	12.0	3.7	5.0	1.7	2.8	3.7	5.6	1.7	5.8	4.2	2.6	5.2	6.5	3.1	17.1	16.0	3.3	4.7	5.3	3.1	1.6
DHX37	"DDX37, Dhr1, KIAA1517, MGC2695, MGC4322"	ENSG00000150990	"DEAH-box helicase 37"	Q8IY37	12	124946825-124989122	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047607	Approved		Approved	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA047607: AB_2680101"	"unprognostic (1.83e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (9.54e-10)"	"unprognostic (2.38e-2)"	"unprognostic (5.14e-2)"	"unprognostic (2.90e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.16e-2)"	"unprognostic (8.28e-3)"	"unprognostic (1.40e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.73e-1)"	9.5	9.2	8.6	12.7	12.1	29.6	9.3	5.7	12.1	8.9	7.9	11.8	6.0	10.2	11.6	6.5	11.2	9.8	10.7	12.4	7.3	5.4	7.4	10.7	8.2	13.3	11.6	7.4	12.7	14.4	4.7	5.7	6.7	10.5	8.7	5.7	5.6	9.1	7.3	22.7	15.8	9.5	7.7	7.5	12.2	9.1	6.8	11.1	7.8	8.9	9.7	11.5	9.7	13.6	4.3	1.6	0.2	2.5	1.4	2.5	1.4	7.4	21.5	3.8	11.8	3.8	4.3	9.7	2.6	3.9	8.6	6.9	27.1	5.2	18.3	10.0	3.1	11.5	10.4	9.9	5.8	3.1	15.8	18.4	9.0	12.2	10.7	5.4	11.8	16.3	4.0	6.6	14.9	2.4	3.4	5.0	9.3	18.9	5.1	5.1	11.0	16.7	12.4	13.8	8.0	13.0	12.3	3.7	9.1	3.7	17.0	6.7	3.3	7.0	7.6	5.7	2.7	8.5	10.5	5.9	10.0	7.5	14.2	17.3	11.7	14.7	18.1	6.6	6.9	12.5	0.0	0.6	0.0	1.5	2.0	2.2	4.3	1.8	2.5	1.6	0.2	0.9	0.8	0.2	1.4	2.5	1.2	0.9	1.4	8.6	12.1	5.7	12.1	7.3	5.4	11.6	7.4	10.5	11.1	3.0	6.9	8.2	2.2	3.8	2.6	3.2	0.0	2.7	4.5	0.0	0.0	3.7	3.3	4.3	1.5	3.6	3.3	0.0	5.3	4.8	3.5	3.1	5.8	6.0	4.6	12.7	8.6	1.8	6.9	1.5	4.9	4.5	0.0	6.4	6.7	2.0	7.2	0.0	2.5	3.9	1.8	6.5	2.7	1.4	5.6	3.4	2.4	4.4	7.3	2.8
DNAJB2	"CMT2T, HSJ1, HSPF3"	ENSG00000135924	"DnaJ heat shock protein family (Hsp40) member B2"	P25686	2	219279267-219286900	"Disease related genes, Predicted intracellular proteins"		Chaperone	Neurodegeneration	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036268	Approved		Enhanced	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA036268: AB_10670793"	"unprognostic (2.02e-2)"	"unprognostic (3.69e-2)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (2.53e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.45e-3)"	"unprognostic (5.11e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.16e-3)"	"unprognostic (7.03e-2)"	"unprognostic (4.09e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.96e-2)"	"unprognostic (5.98e-2)"	"unprognostic (5.62e-3)"	19.9	34.1	48.9	10.1	51.3	14.0	20.9	43.1	62.6	18.4	14.9	51.6	19.8	13.9	13.7	29.0	15.7	25.6	16.3	26.9	52.6	46.8	23.2	16.6	19.4	13.8	65.7	43.4	26.2	41.3	27.8	28.7	16.4	50.0	24.3	10.2	17.2	36.1	23.7	57.5	37.7	14.3	10.3	71.3	14.6	20.7	24.1	54.0	5.2	27.4	10.9	12.1	13.4	41.2	3.8	1.8	5.2	2.9	3.5	2.6	1.1	13.1	5.4	8.7	8.1	18.5	8.9	11.6	12.7	10.7	11.5	9.7	25.3	8.2	8.1	15.5	12.1	26.1	19.0	11.0	14.1	6.5	17.1	4.6	15.9	9.6	12.0	12.3	2.6	14.5	8.6	40.9	12.4	15.3	20.5	5.0	9.1	2.7	9.3	8.4	6.8	4.3	3.2	5.1	11.5	10.2	5.1	7.1	4.8	12.5	9.4	8.0	9.3	14.7	15.1	24.2	24.0	11.2	5.3	6.5	16.6	32.5	4.7	10.9	10.4	3.0	13.3	16.6	2.5	12.1	0.0	1.1	5.2	2.2	1.0	1.7	1.7	2.1	1.9	0.7	3.8	2.6	2.6	1.2	3.5	2.9	1.8	2.2	1.1	48.9	51.3	43.1	51.0	52.6	46.8	65.7	43.4	50.0	54.0	17.9	32.7	22.5	39.8	25.3	96.5	55.2	25.5	32.1	17.0	36.6	53.0	32.3	66.3	51.1	34.5	19.9	30.4	93.5	29.1	27.6	27.7	53.0	25.3	16.3	24.5	76.3	51.5	19.6	16.2	53.9	33.6	17.5	30.4	30.7	37.8	72.2	54.1	23.0	36.7	38.4	79.6	19.4	26.9	45.0	19.3	44.2	57.7	26.6	18.3	19.2
ENDOD1	KIAA0830	ENSG00000149218	"Endonuclease domain containing 1"	O94919	11	95089810-95132645	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 62.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008932, HPA010517"	Enhanced		Approved	"Nuclear membrane"	"Secreted - unknown location"	NA	NA		19000000	"Nuclear membrane"		"HPA008932: AB_2262252, HPA010517: AB_1852351"	"unprognostic (8.81e-3)"	"unprognostic (1.92e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.34e-2)"	"unprognostic (2.78e-2)"	"unprognostic (4.43e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.65e-1)"	"prognostic unfavorable (8.86e-4)"	"unprognostic (2.84e-1)"	"prognostic favorable (6.64e-7)"	"unprognostic (5.92e-2)"	"unprognostic (2.35e-1)"	"unprognostic (5.62e-3)"	"prognostic unfavorable (3.27e-4)"	14.9	13.8	20.3	7.9	27.9	4.1	15.0	14.3	31.0	17.6	25.4	52.6	9.7	8.4	13.7	12.2	19.0	13.1	12.2	14.4	24.0	22.3	18.9	4.9	10.6	7.3	33.5	20.1	12.0	4.7	48.8	11.8	12.1	40.6	36.5	29.4	15.5	12.5	22.9	34.4	20.6	14.5	16.2	40.4	22.9	8.3	9.3	25.5	0.5	12.6	12.3	6.7	9.0	16.5	7.3	2.9	1.3	5.4	3.1	5.9	6.1	1.1	1.7	2.2	1.3	62.5	20.0	9.2	8.3	1.8	2.2	2.3	8.6	15.1	8.0	10.3	6.6	5.0	11.1	2.1	11.4	0.8	6.3	1.6	17.3	0.8	3.6	6.8	3.1	22.4	18.1	14.9	1.3	4.2	15.3	7.7	7.7	3.5	5.2	8.3	2.9	1.3	0.1	0.5	12.4	5.6	5.8	0.0	3.3	6.6	9.3	1.1	0.9	3.5	3.5	6.2	3.1	3.6	0.9	5.5	12.2	3.6	8.1	3.5	4.3	3.2	0.6	3.7	1.7	27.2	1.3	1.3	0.9	5.9	3.2	5.5	7.2	3.9	5.0	2.9	7.3	3.2	3.8	0.6	3.1	5.4	1.3	2.2	6.1	20.3	27.9	14.3	31.0	24.0	22.3	33.5	20.1	40.6	25.5	8.9	14.2	11.5	14.8	7.1	2.1	4.4	17.8	1.4	11.4	10.4	0.0	4.6	1.7	4.5	2.5	22.4	35.5	23.3	7.7	6.5	8.6	20.7	13.9	2.9	2.9	0.0	15.5	38.1	4.3	2.6	9.5	5.5	27.0	1.0	22.5	1.9	6.1	40.2	14.2	9.3	0.6	38.8	19.1	0.3	3.6	10.9	10.4	5.1	18.4	8.6
FA2H	"FAAH, FAXDC1, FLJ25287, SPG35"	ENSG00000103089	"Fatty acid 2-hydroxylase"	Q7L5A8	16	74712955-74774831	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism"	Oxidoreductase	"Disease mutation, Hereditary spastic paraplegia, Leukodystrophy, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 78.2;stomach 1: 45.5"	"Cell type enhanced"	"Detected in many"	20	"Mucus-secreting cells: 34.0;Paneth cells: 56.1;Urothelial cells: 163.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	24	"memory B-cell: 3.0"	"Lineage enriched"	"Detected in single"	24	"B-cells: 3.0"	"Cell line enhanced"	"Detected in some"		"A549: 16.0;HAP1: 20.7;JURKAT: 38.1;OE19: 25.5;SK-BR-3: 12.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056614, HPA077840"	Approved		Uncertain	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA056614: AB_2683191, HPA077840: AB_2686858"	"unprognostic (1.33e-1)"	"unprognostic (4.97e-2)"	"unprognostic (9.19e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (3.74e-4)"	"unprognostic (6.01e-2)"	"prognostic favorable (5.01e-6)"	"unprognostic (1.50e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.11e-3)"	0.7	0.7	11.8	3.4	27.7	0.7	2.6	2.8	25.3	2.0	16.2	62.4	0.0	8.1	0.7	2.2	3.7	1.8	14.3	0.7	22.3	11.0	3.7	0.7	1.5	0.9	40.5	16.5	0.6	6.8	7.1	0.8	1.0	28.5	1.9	15.4	0.0	8.4	1.0	0.6	3.5	11.3	1.4	78.2	0.8	45.5	2.4	44.6	2.6	2.0	0.0	4.7	3.8	1.2	3.0	0.0	0.0	0.0	0.1	0.0	0.0	3.8	16.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.2	0.0	8.7	8.9	0.0	0.0	0.0	0.9	1.5	20.7	0.2	0.0	0.0	0.6	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	38.1	0.0	0.0	0.0	6.3	0.3	0.0	0.4	25.5	1.0	0.0	0.0	0.7	10.1	6.5	2.8	0.0	0.0	12.3	0.0	0.5	3.7	0.0	0.0	0.0	0.0	0.0	0.1	0.6	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	11.8	27.7	2.8	16.1	22.3	11.0	40.5	16.5	28.5	44.6	0.0	2.2	0.0	4.2	0.5	0.0	0.3	10.2	4.0	2.3	0.0	0.0	0.2	6.6	11.5	6.3	0.0	25.4	0.0	12.9	0.1	0.0	20.7	0.0	0.0	0.1	0.0	6.4	0.0	0.0	2.7	0.0	0.0	3.3	0.0	34.0	0.0	26.4	56.1	0.4	0.0	0.0	0.0	0.1	0.5	2.1	0.6	0.1	0.0	16.8	163.9
FOLR1	FOLR	ENSG00000110195	"Folate receptor 1"	P15328	11	72189558-72196323	"Disease related genes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters"	Transport	Receptor	Neurodegeneration	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 157.6;salivary gland: 101.2"	"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 1: 461.6;Club cells: 316.2;Collecting duct cells: 301.8;Cytotrophoblasts: 307.8;Proximal tubular cells: 286.0;Syncytiotrophoblasts: 216.6"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 259.5"	"Region enriched"	"Detected in many"	20	"pons and medulla: 157.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HeLa: 83.6;RPTEC TERT1: 88.8"	"Group enriched"	"Detected in many"	5	"basal ganglia: 23.1;hippocampal formation: 49.6;pons and medulla: 45.9;thalamus: 34.0"	"Low region specificity"	"Detected in all"			HPA077030			Approved	"Nuclear membrane"	"Secreted to blood"	NA	NA		81000	"Nuclear membrane"		"HPA077030: "	"unprognostic (3.30e-1)"	"unprognostic (2.19e-1)"	"unprognostic (6.55e-2)"	"unprognostic (3.49e-2)"	"unprognostic (7.67e-3)"	"unprognostic (1.98e-2)"	"prognostic unfavorable (2.50e-4)"	"unprognostic (1.18e-2)"	"unprognostic (8.13e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.87e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.69e-1)"	0.0	0.7	1.3	0.2	1.7	0.0	6.6	0.6	3.5	31.4	0.1	21.4	2.8	0.0	1.0	3.5	1.6	46.7	1.0	0.2	7.9	1.8	38.8	0.2	47.0	0.0	0.8	0.4	8.9	1.8	0.4	3.5	24.5	157.6	1.5	0.0	17.0	101.2	4.0	0.1	0.9	0.1	0.0	0.7	0.0	7.4	0.4	0.2	0.0	12.7	2.6	3.5	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	7.8	7.9	0.0	8.1	0.1	0.0	0.1	0.4	0.3	0.0	0.0	0.2	0.1	83.6	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	2.7	0.0	88.8	0.0	0.0	0.5	0.2	1.2	0.0	7.3	11.4	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	1.3	1.7	0.6	3.5	7.9	1.8	0.8	0.4	157.6	0.2	461.6	156.4	0.0	7.8	0.8	0.0	0.3	35.7	178.0	316.2	301.8	0.0	307.8	112.7	15.6	0.0	0.0	0.0	0.0	1.2	101.0	3.8	4.7	4.7	0.0	26.1	0.0	1.7	0.0	0.0	0.0	0.6	0.8	0.0	0.0	0.0	1.4	4.1	0.0	0.0	286.0	0.0	0.0	0.1	0.0	0.1	0.1	216.6	0.0	0.0	8.6
KCNJ13	"Kir1.4, Kir7.1, LCA16"	ENSG00000115474	"Potassium voltage-gated channel subfamily J member 13"	O60928	2	232766464-232776568	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Cataract, Disease mutation, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 22.9;intestine: 49.5;retina: 70.3"	"Group enriched"	"Detected in some"	14	"Melanocytes: 20.3;Muller glia cells: 44.0"	"Cancer enriched"	"Detected in some"	5	"melanoma: 5.9"	"Region enriched"	"Detected in some"	7	"pons and medulla: 22.9"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.7;CACO-2: 2.6;SuSa: 3.1;U-2197: 4.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051609			Approved	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA051609: "	"unprognostic (4.29e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.69e-1)"	"unprognostic (9.03e-5)"	"unprognostic (1.17e-1)"	"unprognostic (3.12e-2)"		"unprognostic (2.26e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.11e-2)"	0.2	0.2	0.5	0.0	0.7	0.1	0.3	0.4	0.9	0.2	10.1	7.0	1.3	4.3	0.2	0.3	0.2	0.1	1.6	0.2	3.2	0.5	1.9	0.3	0.2	0.0	0.4	0.4	0.3	0.4	8.5	0.3	0.0	22.9	0.3	0.0	70.3	0.3	1.6	0.2	1.8	49.5	0.0	0.6	0.2	1.1	0.5	0.1	0.0	3.8	0.0	0.0	0.3	0.3	1.1	0.8	5.4	1.1	1.1	2.7	0.1	0.1	0.0	0.0	0.2	0.0	0.0	1.7	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	1.0	0.0	0.5	0.0	0.3	0.2	0.0	0.9	0.0	0.0	0.4	0.0	0.6	0.0	0.1	0.0	0.3	1.0	3.1	0.2	0.3	0.0	0.1	0.0	4.6	0.3	1.3	0.1	0.8	0.8	0.4	0.0	5.4	1.1	0.9	1.0	0.2	1.2	0.8	1.8	0.7	0.4	1.1	2.1	1.1	0.8	1.1	1.0	0.8	2.7	0.1	0.5	0.7	0.4	0.9	3.2	0.5	0.4	0.4	22.9	0.1	0.0	0.0	0.0	0.0	0.5	0.6	0.2	0.0	0.0	0.0	1.8	0.0	0.0	1.7	0.0	2.4	0.0	1.0	0.0	1.1	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.3	0.0	0.0	44.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
LBR	"DHCR14B, TDRD18"	ENSG00000143815	"Lamin B receptor"	Q14739	1	225401502-225428925	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	"DNA-binding, Oxidoreductase, Receptor"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 88.7"	"Cell type enhanced"	"Detected in many"	5	"Erythroid cells: 163.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049840, HPA062236"	Enhanced		Enhanced	"Nuclear membrane"		NA	Yes			"Nuclear membrane"		"HPA049840: AB_2680908, HPA062236: AB_2684721"	"unprognostic (2.57e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.32e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (7.30e-4)"	"unprognostic (3.60e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.99e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.08e-1)"	"unprognostic (5.45e-1)"	"unprognostic (8.32e-2)"	"unprognostic (2.78e-1)"	16.7	4.2	5.6	22.9	7.8	37.0	14.6	5.5	7.2	23.4	37.7	14.5	10.8	16.8	31.4	19.5	17.2	21.8	11.1	7.2	6.5	6.1	15.4	18.9	12.3	31.0	9.9	4.2	14.3	11.8	2.4	5.0	11.2	9.4	19.6	19.7	6.2	8.2	16.6	6.8	7.3	20.4	32.8	9.9	25.4	21.5	8.0	8.9	88.7	8.7	6.9	28.1	28.8	16.2	14.1	13.1	70.9	15.0	12.2	19.9	20.2	25.1	9.9	33.5	14.9	14.1	8.8	16.9	6.6	8.4	13.9	14.9	19.8	43.4	51.9	14.8	6.9	8.3	19.2	23.9	7.0	21.0	30.2	24.8	12.9	9.6	16.9	8.7	56.1	22.9	7.6	4.5	12.6	11.2	7.2	17.6	25.7	39.1	35.3	9.3	3.5	51.4	31.7	30.2	24.7	3.4	34.7	30.5	48.3	15.9	11.8	9.0	11.9	11.3	8.4	5.5	15.2	11.5	37.0	11.5	3.8	20.0	10.7	23.8	12.7	17.3	58.0	5.2	25.4	13.0	22.2	15.0	21.1	15.3	10.1	17.1	13.8	14.6	16.2	13.1	14.1	14.7	17.4	70.9	12.2	7.8	6.6	19.9	20.2	5.6	7.8	5.5	7.2	6.5	6.1	9.9	4.2	9.4	8.9	26.8	31.3	74.4	22.1	24.0	4.2	5.1	50.9	28.1	45.5	29.6	5.9	27.8	5.0	20.9	0.7	42.7	17.2	163.5	17.2	18.7	25.9	27.1	9.3	64.4	38.4	11.1	25.9	44.2	84.0	2.3	31.4	51.1	25.3	15.4	30.9	12.0	18.1	21.0	30.4	22.5	9.8	38.8	33.0	14.0	27.7	31.0	9.3	46.3	62.8	28.9
LEMD2	"dJ482C21.1, NET25"	ENSG00000161904	"LEM domain containing 2"	Q8NC56	6	33771202-33789136	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017340	Supported		Supported	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA017340: AB_2296925"	"unprognostic (9.01e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.12e-2)"	"unprognostic (2.98e-1)"	"unprognostic (8.29e-3)"	"unprognostic (6.53e-2)"	"unprognostic (5.98e-2)"	"unprognostic (4.42e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.67e-3)"	"unprognostic (2.11e-2)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (2.43e-1)"	"unprognostic (7.54e-2)"	"unprognostic (3.82e-2)"	"unprognostic (7.12e-2)"	18.7	24.1	23.9	22.9	30.4	37.8	23.5	49.0	26.0	25.2	22.0	31.1	17.9	21.8	24.3	28.7	23.6	22.3	20.7	19.6	24.0	18.3	22.5	22.8	23.9	28.3	32.2	17.3	28.1	26.9	31.6	28.5	29.2	25.5	24.9	21.2	28.9	23.5	24.1	17.1	34.9	25.8	25.9	21.8	34.4	21.0	20.0	27.7	18.7	28.0	15.6	27.8	18.3	27.2	5.4	6.9	6.8	4.5	3.0	7.2	2.5	12.7	14.7	25.0	24.2	14.3	15.5	18.8	14.0	21.9	18.1	19.2	11.1	13.8	12.0	19.8	20.1	51.0	22.4	14.5	18.9	12.8	12.5	13.4	4.5	14.8	14.4	30.0	9.0	15.8	16.7	36.1	19.2	33.1	30.0	19.3	16.0	12.6	14.1	15.7	10.9	16.9	22.7	14.3	19.2	8.5	11.1	10.3	10.0	19.3	18.3	17.8	14.2	8.4	26.9	18.2	26.5	18.2	25.2	8.9	25.4	9.9	13.5	16.4	18.3	14.5	8.5	10.0	14.5	30.3	3.8	4.1	6.8	5.9	3.7	7.2	5.2	6.3	5.6	3.9	5.4	5.0	6.0	3.3	3.0	4.5	6.9	6.3	2.5	23.9	30.4	49.0	26.0	24.0	18.3	32.2	17.3	25.5	27.7	3.0	7.0	8.2	11.4	9.6	17.6	9.0	5.1	2.7	2.3	8.7	17.7	22.1	1.7	7.6	19.6	15.7	15.2	23.3	5.8	29.7	12.2	11.1	12.7	6.8	15.3	41.3	5.2	12.3	13.2	30.2	9.8	11.5	11.8	5.4	16.0	14.5	11.1	17.5	15.2	6.0	12.3	19.4	15.9	17.6	7.2	8.9	24.9	11.7	14.3	11.0
LEMD3	MAN1	ENSG00000174106	"LEM domain containing 3"	Q9Y2U8	12	65169571-65248327	"Disease related genes, Plasma proteins, Predicted membrane proteins"		DNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025078, HPA076986"	Uncertain		Supported	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA025078: AB_10601908, HPA076986: AB_2686821"	"unprognostic (2.10e-2)"	"unprognostic (6.83e-3)"	"unprognostic (1.63e-3)"	"unprognostic (1.76e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.68e-3)"	"unprognostic (7.22e-2)"	"unprognostic (3.06e-2)"	"unprognostic (4.16e-2)"	"unprognostic (8.89e-2)"	"unprognostic (2.43e-1)"	"prognostic favorable (2.30e-4)"	"unprognostic (4.37e-2)"	"unprognostic (3.93e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.72e-1)"	13.7	11.9	21.9	15.3	27.3	24.8	15.3	36.0	26.3	13.3	14.4	10.9	11.4	13.4	18.0	13.1	14.5	14.3	10.0	11.1	19.4	12.5	14.2	13.3	13.9	17.2	15.8	16.9	17.8	16.4	25.7	15.2	10.4	16.9	14.0	14.6	12.1	14.8	11.9	14.9	13.3	14.8	12.1	15.8	16.2	13.5	28.6	19.6	23.2	15.3	8.4	16.7	13.1	15.8	4.8	5.0	3.1	2.1	3.8	5.3	1.6	11.6	6.6	10.7	10.6	7.5	8.8	7.3	13.7	7.4	6.9	6.0	8.2	7.6	32.0	8.8	8.4	5.3	15.9	11.4	9.8	10.0	7.6	13.2	13.0	6.3	6.3	5.8	19.7	9.5	6.3	10.6	8.2	11.1	9.8	8.1	9.0	17.0	15.3	9.6	6.9	10.3	10.3	14.6	5.3	6.8	24.3	10.5	15.9	8.7	13.0	11.1	6.9	13.7	14.0	8.2	10.7	14.0	15.7	11.0	8.4	9.1	7.9	9.4	10.9	10.3	19.7	7.1	9.7	10.3	2.3	1.8	3.1	3.9	1.6	5.0	4.5	5.2	5.2	2.4	4.8	5.0	5.3	2.1	3.8	2.1	5.0	4.1	1.6	21.9	27.3	36.0	26.3	19.4	12.5	15.8	16.9	16.9	19.6	35.7	15.2	15.9	16.0	28.5	19.5	14.6	5.1	21.4	13.6	10.4	17.7	6.6	0.0	9.2	1.5	14.3	13.1	23.3	11.2	3.6	13.1	17.1	21.9	11.9	5.6	15.9	14.3	8.6	17.7	2.4	14.7	10.8	16.9	10.0	11.9	19.1	11.6	14.2	11.7	4.5	19.5	6.5	17.9	47.2	39.4	34.3	12.0	15.4	11.2	19.0
LMNB1		ENSG00000113368	"Lamin B1"	P20700	5	126776623-126837020	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			Leukodystrophy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 93.1"	"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 61.8;Extravillous trophoblasts: 58.3;granulocytes: 89.2;Late spermatids: 58.6;monocytes: 77.5"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"cerebellum: 23.4;pons and medulla: 6.3"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005269, HPA050524, CAB079757"	Supported		Supported	"Nuclear membrane"		NA	NA		3300000	"Nuclear membrane"		"CAB005269: AB_648156, CAB079757: AB_2665863, HPA050524: AB_2681156"	"unprognostic (1.52e-1)"	"unprognostic (2.53e-2)"	"unprognostic (4.96e-3)"	"unprognostic (3.70e-2)"	"unprognostic (1.61e-1)"	"unprognostic (8.65e-3)"	"prognostic unfavorable (3.08e-6)"	"unprognostic (2.06e-2)"	"unprognostic (6.62e-3)"	"unprognostic (5.28e-2)"	"unprognostic (2.13e-3)"	"unprognostic (2.33e-2)"	"prognostic unfavorable (3.33e-16)"	"unprognostic (1.33e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.55e-1)"	3.9	2.0	2.5	36.8	3.5	21.1	7.0	23.4	2.5	3.1	10.6	0.5	3.9	8.2	2.2	3.2	15.8	2.4	4.3	3.3	3.0	2.7	2.4	5.0	9.7	25.4	2.1	1.7	2.9	2.9	1.0	3.4	5.2	6.3	1.9	9.9	1.7	4.1	5.7	1.8	6.2	11.1	2.6	8.8	15.3	5.7	2.5	2.3	93.1	2.0	9.3	20.3	4.1	5.1	3.8	13.2	8.5	12.2	1.9	10.5	4.9	25.3	8.4	26.3	25.1	0.6	1.9	34.1	11.9	3.5	13.2	14.3	21.9	21.2	44.1	20.7	4.1	6.3	14.2	17.9	8.1	14.6	30.9	22.0	28.3	10.0	12.8	0.2	33.6	19.1	0.5	0.1	6.9	3.2	2.5	10.8	18.1	16.4	17.2	9.2	20.9	60.8	66.7	19.8	10.4	11.9	29.1	52.0	17.8	7.2	11.6	30.5	16.1	19.2	8.3	7.2	9.5	15.1	38.9	9.1	9.9	26.9	7.3	25.4	11.4	8.7	38.7	5.0	47.8	14.6	1.2	12.2	4.0	1.9	5.0	1.5	3.8	4.0	2.5	13.2	2.9	2.9	2.6	8.5	1.9	1.2	4.0	10.5	4.9	2.5	3.5	23.4	2.5	3.0	2.7	2.1	1.7	6.3	2.3	0.0	7.0	22.9	2.4	4.4	6.1	0.8	7.6	2.7	4.5	0.0	7.9	14.6	1.7	1.9	61.8	3.8	2.3	0.0	0.7	58.3	2.9	1.0	89.2	2.4	18.5	4.8	5.8	1.8	18.2	58.6	2.0	12.5	1.7	77.5	13.5	2.8	0.9	10.5	0.4	1.7	16.5	0.0	4.2	2.8	8.1	4.6	3.9	20.8	25.7	0.4
LMNB2	LMN2	ENSG00000176619	"Lamin B2"	Q03252	19	2427638-2456996	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 144.2;Extravillous trophoblasts: 66.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022593, HPA047863, HPA062477"	Enhanced		Supported	"Nuclear membrane"		NA	NA		97000	"Nuclear membrane"		"CAB022593: , HPA047863: AB_2680189, HPA062477: AB_2684776"	"unprognostic (3.92e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.76e-2)"	"unprognostic (4.05e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (2.53e-3)"	"prognostic unfavorable (5.88e-4)"	"unprognostic (1.96e-1)"	"unprognostic (3.09e-3)"	"prognostic unfavorable (9.53e-5)"	"prognostic unfavorable (9.34e-5)"	"prognostic favorable (3.98e-4)"	"unprognostic (4.03e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.53e-2)"	5.6	5.0	4.6	11.5	6.0	11.8	8.6	8.9	5.9	3.7	8.2	4.3	5.1	8.7	10.1	3.6	7.9	5.1	5.9	5.4	4.3	5.0	4.2	4.4	5.7	9.3	5.3	5.4	7.0	5.1	2.3	5.4	11.6	5.2	5.0	4.8	4.5	5.3	4.1	10.1	7.7	9.6	4.1	3.4	6.0	7.5	7.4	4.4	18.4	5.4	12.4	8.7	4.1	11.3	1.6	7.3	1.6	4.0	1.6	3.5	1.2	45.8	29.5	21.4	27.8	4.7	7.4	28.6	31.0	15.2	31.3	23.8	38.9	19.7	21.4	12.8	14.4	18.1	48.3	19.0	22.0	16.1	26.0	22.7	17.0	10.4	30.3	5.7	23.7	17.3	6.6	5.6	16.8	13.3	5.8	16.0	20.0	29.5	13.8	14.7	26.7	27.0	13.1	40.8	24.9	25.9	38.2	27.2	17.9	8.9	23.2	31.7	18.4	25.9	17.3	10.3	12.4	17.4	24.5	22.1	30.2	31.6	46.4	46.2	12.3	10.4	21.6	24.5	22.7	38.8	0.0	1.4	1.6	2.3	1.3	3.5	0.9	2.5	2.2	1.7	1.6	2.6	2.9	0.1	1.6	4.0	7.3	0.7	1.2	4.6	6.0	8.9	5.9	4.3	5.0	5.3	5.4	5.2	4.4	3.0	3.4	6.7	10.1	18.3	9.0	5.0	2.5	4.0	4.5	5.2	7.9	16.3	8.3	7.1	144.2	13.1	10.5	23.3	10.0	66.7	11.3	12.7	4.6	2.5	17.9	12.7	5.8	5.5	6.7	16.6	8.6	7.8	1.7	15.4	13.1	8.2	9.3	8.6	7.4	4.3	7.7	12.9	11.9	6.5	13.8	17.6	11.6	7.5	16.6	17.7
NANP	"C20orf147, dJ694B14.3, HDHD4, MGC26833"	ENSG00000170191	"N-acetylneuraminic acid phosphatase"	Q8TBE9	20	25612935-25624175	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA050342	Uncertain		Approved	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA050342: AB_2681098"	"unprognostic (8.72e-2)"	"unprognostic (1.88e-1)"	"unprognostic (7.42e-3)"	"unprognostic (6.01e-2)"	"unprognostic (5.59e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (9.01e-6)"	"unprognostic (3.20e-1)"	"unprognostic (3.75e-2)"	"unprognostic (7.70e-3)"	"unprognostic (1.24e-1)"	"unprognostic (3.46e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.71e-2)"	"unprognostic (9.42e-2)"	10.0	14.0	6.3	6.0	7.4	6.9	7.2	13.3	8.2	6.3	6.4	4.1	4.3	7.1	6.9	5.7	9.5	6.2	6.2	6.8	4.3	4.8	11.6	12.5	6.7	4.4	4.2	3.3	12.0	7.4	8.0	8.6	6.0	6.5	5.6	6.2	7.1	7.8	6.1	9.2	4.9	7.6	6.9	5.6	7.1	6.2	6.6	3.7	18.2	9.0	6.0	6.8	7.4	6.8	1.7	6.4	1.7	4.5	4.9	4.2	2.3	11.1	6.5	5.3	7.7	8.6	9.2	7.8	5.7	11.2	7.6	9.8	5.9	7.7	4.0	6.5	10.8	9.0	7.1	8.1	8.2	14.8	1.4	4.8	10.0	3.1	15.7	7.2	7.6	3.0	8.0	4.1	8.5	10.9	4.2	6.4	13.8	8.4	7.2	9.2	6.1	15.0	3.8	3.9	9.7	10.2	7.5	11.2	4.9	4.4	6.0	10.2	4.2	6.3	10.2	6.7	5.6	4.4	6.5	5.4	12.1	9.0	11.1	8.0	3.8	3.5	10.0	3.4	17.7	7.2	0.4	4.5	1.7	2.8	4.5	4.2	1.4	2.0	2.1	6.4	1.7	1.8	3.1	0.3	4.9	2.4	1.4	1.7	2.3	6.3	7.4	13.3	8.2	4.3	4.8	4.2	3.3	6.5	3.7	3.0	1.0	1.5	3.4	5.3	4.6	3.1	5.1	0.0	2.3	7.0	0.0	3.4	11.6	4.4	0.3	4.5	1.3	0.0	3.7	1.6	4.6	2.4	5.7	4.9	3.9	6.4	2.9	4.3	2.5	0.0	2.8	3.7	5.0	1.0	2.6	5.6	4.4	2.0	2.5	7.1	6.8	0.0	3.9	2.6	10.7	4.4	1.6	1.5	2.5	2.3
NRM	NRM29	ENSG00000137404	Nurim	Q8IXM6	6	30688047-30691420	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 44.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA072545, HPA073982"			Enhanced	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA072545: AB_2686532, HPA073982: AB_2686649"	"unprognostic (2.09e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.13e-3)"	"unprognostic (1.30e-1)"	"unprognostic (8.44e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.44e-1)"	"prognostic unfavorable (3.52e-8)"	"unprognostic (3.95e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.51e-1)"	14.2	5.6	1.4	6.5	2.4	10.0	11.4	2.2	2.5	16.2	6.6	2.9	5.8	2.6	15.3	5.3	11.4	7.7	7.4	7.5	1.5	1.4	7.3	3.0	8.1	15.7	2.1	1.5	13.7	5.7	3.6	1.7	11.3	2.4	10.4	4.2	5.4	4.2	7.0	4.5	9.0	6.0	7.4	2.4	9.6	4.2	9.7	2.2	23.3	5.0	14.4	11.9	9.9	9.2	4.2	3.7	1.6	3.8	0.8	1.6	1.0	3.8	3.7	6.9	4.8	1.1	3.8	0.8	1.9	3.9	6.2	5.7	3.9	2.7	6.5	1.4	4.0	2.8	6.0	3.8	6.5	1.8	9.0	2.0	4.0	5.3	5.1	1.4	3.1	6.1	2.3	2.4	6.0	2.3	2.1	4.8	5.4	3.5	6.0	4.2	3.4	4.8	3.3	1.4	4.3	2.2	11.7	4.6	7.9	2.7	2.0	2.6	2.2	2.2	2.8	1.2	2.2	4.5	3.0	1.9	5.7	3.1	3.2	3.5	2.2	4.0	2.3	0.9	8.3	7.3	0.9	3.8	0.2	1.0	1.1	0.8	4.2	1.1	1.6	3.3	4.1	0.5	0.6	1.6	0.8	0.4	3.7	0.8	1.0	1.4	2.4	2.2	2.5	1.5	1.4	2.1	1.5	2.4	2.2	3.0	1.3	16.4	5.8	8.8	0.2	1.6	10.2	0.0	6.8	1.8	2.0	15.7	3.3	9.9	8.4	11.7	0.2	0.0	5.0	23.5	13.6	1.2	12.7	0.8	15.3	3.2	1.2	1.8	21.2	44.7	5.2	14.9	3.3	27.9	1.9	1.1	5.2	0.0	5.6	0.6	1.5	6.5	9.2	4.5	1.7	5.5	4.2	8.6	3.0	2.6
NUP133	FLJ10814	ENSG00000069248	"Nucleoporin 133"	Q8WUM0	1	229440260-229508341	"Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059767	Approved		Supported	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA059767: AB_2684123"	"unprognostic (2.05e-2)"	"unprognostic (3.54e-1)"	"unprognostic (5.75e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.20e-2)"	"unprognostic (5.72e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.93e-2)"	"unprognostic (3.48e-1)"	"unprognostic (8.31e-2)"	"unprognostic (2.22e-1)"	"unprognostic (7.01e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.30e-2)"	20.6	20.0	17.4	16.3	21.6	16.2	25.4	29.8	24.0	19.6	17.7	27.2	15.5	13.2	23.0	18.4	18.5	22.2	13.5	22.7	17.6	17.0	19.5	15.6	19.8	27.8	20.9	20.3	27.3	17.8	33.3	23.3	23.0	20.6	19.1	18.3	15.5	17.8	21.2	28.6	21.8	16.2	20.9	19.4	19.1	17.1	19.4	20.9	38.0	21.7	18.0	22.8	20.2	17.9	9.0	10.5	7.5	13.6	7.6	10.9	7.3	14.3	11.6	18.2	9.4	13.1	14.1	35.5	11.9	12.2	17.8	16.2	13.7	14.2	20.9	10.4	11.8	7.9	19.1	25.1	12.6	19.1	12.6	31.2	12.6	12.0	10.3	10.5	25.5	10.3	11.0	9.5	12.8	15.3	12.4	14.8	18.0	28.4	10.1	13.9	6.5	18.8	10.9	27.2	20.2	10.6	18.4	18.9	20.5	10.1	12.7	15.6	19.4	17.8	11.2	13.0	9.3	17.4	20.3	12.9	8.1	9.9	14.0	17.7	9.7	12.0	22.5	9.2	14.9	16.8	7.5	8.2	6.1	8.8	8.2	10.9	9.0	9.3	9.7	10.5	7.1	9.6	10.0	2.9	7.6	13.6	6.0	8.6	7.3	17.4	21.6	29.8	23.4	17.6	17.0	20.9	20.3	20.6	20.9	8.9	17.6	3.7	5.2	8.0	16.0	17.3	7.6	9.4	10.3	14.0	7.9	18.2	5.0	7.2	1.1	8.7	2.9	0.0	7.4	11.1	10.6	5.8	7.0	9.5	8.5	15.9	9.8	12.3	12.3	1.9	11.5	7.1	6.8	9.0	7.1	11.6	6.2	6.5	11.3	6.8	11.9	0.0	9.9	12.3	16.7	9.4	15.3	7.0	9.5	5.5
NUP153	HNUP153	ENSG00000124789	"Nucleoporin 153"	P49790	6	17615035-17706834	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport, Viral penetration into host nucleus, Virus entry into host cell"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027896, HPA027897, HPA027898, HPA027899"	Supported		Enhanced	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA027896: AB_10611243, HPA027897: AB_10601108, HPA027898: AB_10601682, HPA027899: "	"unprognostic (2.49e-1)"	"unprognostic (5.37e-1)"	"unprognostic (3.17e-2)"	"unprognostic (6.20e-3)"	"unprognostic (3.36e-1)"	"unprognostic (7.64e-3)"	"unprognostic (2.53e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.95e-2)"	"unprognostic (7.16e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.66e-1)"	"unprognostic (5.40e-2)"	"unprognostic (8.69e-2)"	20.2	14.0	13.8	22.2	15.3	37.5	19.0	24.7	14.9	17.8	15.2	14.4	18.9	9.8	19.7	16.0	21.6	17.8	15.6	15.1	12.3	10.2	13.4	22.9	17.7	21.6	12.2	10.5	21.0	15.1	23.3	17.3	29.2	12.6	15.1	13.4	12.4	16.3	19.9	30.7	19.9	16.3	16.0	11.0	18.7	15.0	26.8	13.8	34.4	15.9	18.9	26.4	18.4	21.1	3.9	3.5	6.5	3.3	5.5	7.6	2.2	19.2	9.7	21.4	18.6	9.5	11.2	20.8	15.1	14.4	23.1	24.8	16.1	9.0	36.6	25.3	13.7	19.2	14.1	25.0	14.9	37.5	19.2	18.6	19.6	10.7	16.6	7.1	28.3	18.3	11.8	12.1	24.1	17.5	8.8	13.6	12.4	45.4	11.8	15.5	10.4	20.9	17.2	16.6	7.4	10.5	27.7	27.4	34.4	10.2	19.1	23.7	13.7	12.9	21.4	12.9	35.4	13.8	10.3	12.4	23.5	13.3	11.0	23.5	15.0	21.5	37.0	5.8	13.1	27.6	2.4	2.5	5.5	5.9	2.4	7.6	3.6	7.1	6.8	3.5	3.9	4.4	4.3	6.5	5.5	3.3	2.0	3.1	2.2	13.8	15.3	24.7	14.9	12.3	10.2	12.2	10.5	12.6	13.8	17.9	21.0	16.6	35.4	67.9	13.1	10.9	10.2	17.4	11.4	15.7	15.7	17.8	1.7	7.7	20.7	23.4	10.7	0.0	5.2	18.0	24.9	29.7	3.5	24.5	15.1	15.9	20.1	12.9	17.1	16.4	16.1	16.8	20.3	6.4	12.1	8.0	12.4	3.5	13.8	9.1	12.5	12.9	23.6	29.1	20.3	69.4	20.0	20.2	14.6	28.0
NUP155	"KIAA0791, N155"	ENSG00000113569	"Nucleoporin 155"	O75694	5	37288137-37371181	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Atrial fibrillation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"lymphoid tissue: 20.4;testis: 70.1"	"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 50.6;Late spermatids: 71.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037775	Enhanced		Enhanced	"Nuclear membrane"	"Intracellular and membrane"	NA	NA			"Nuclear membrane"		"HPA037775: AB_10671885"	"unprognostic (1.10e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.28e-2)"	"unprognostic (8.58e-3)"	"unprognostic (7.14e-2)"	"unprognostic (6.30e-2)"	"prognostic unfavorable (1.35e-6)"	"unprognostic (2.18e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.51e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.49e-2)"	"unprognostic (6.80e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.05e-1)"	6.8	5.3	3.9	6.5	5.9	11.2	7.3	6.9	7.5	6.4	5.1	5.9	3.4	4.4	9.7	3.7	6.9	5.0	3.7	4.7	3.9	4.1	4.4	5.3	5.1	8.1	3.8	4.2	7.9	5.5	8.1	7.0	8.4	5.2	5.5	6.3	5.9	6.0	5.9	6.1	8.1	5.0	5.9	3.9	7.2	4.9	70.1	2.5	20.4	5.4	4.8	9.8	5.8	6.0	7.3	4.9	7.1	7.1	7.7	10.0	4.4	13.8	11.0	12.0	17.7	3.7	5.5	43.1	11.2	5.9	15.4	11.3	16.2	11.4	15.7	5.2	7.2	16.7	11.3	20.2	11.0	24.2	10.3	11.4	12.2	40.1	7.5	4.7	20.3	8.6	4.0	4.6	23.7	12.0	4.2	8.1	7.1	22.1	8.4	10.2	6.8	10.8	5.5	11.3	8.5	10.0	13.1	37.8	12.5	3.5	13.3	14.5	10.0	25.8	11.1	6.5	8.9	13.7	8.1	7.0	18.6	15.6	14.0	17.0	9.6	16.0	21.1	8.7	18.4	14.0	7.1	3.4	5.8	6.1	7.1	10.0	7.3	5.7	5.3	4.9	5.8	5.8	6.5	1.3	7.7	5.0	3.4	4.1	4.4	3.9	5.9	6.9	7.5	3.9	4.1	3.8	4.2	5.2	2.5	3.0	5.0	11.5	5.6	9.3	6.5	7.3	2.5	12.0	11.4	3.5	5.9	11.9	0.0	5.9	50.6	7.4	3.8	0.0	5.2	17.5	5.8	6.6	4.7	7.9	6.8	4.8	1.2	13.5	8.8	71.9	10.3	7.4	0.0	4.6	9.7	3.5	5.5	3.5	9.6	3.1	13.1	0.0	6.1	27.7	19.6	10.2	6.3	8.7	10.3	4.4
RNF6	DKFZp686P0776	ENSG00000127870	"Ring finger protein 6"	Q9Y252	13	26132115-26222493	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 129.7;Spermatocytes: 94.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039343, HPA040048"	Approved		Supported	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA039343: AB_2676456, HPA040048: AB_10672969"	"unprognostic (3.22e-1)"	"prognostic unfavorable (3.07e-4)"	"unprognostic (1.45e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.07e-2)"	"unprognostic (7.63e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.21e-2)"	"unprognostic (2.70e-2)"	"unprognostic (8.35e-3)"	"unprognostic (1.84e-1)"	"unprognostic (7.70e-2)"	"unprognostic (8.47e-2)"	16.4	19.8	22.3	15.9	27.5	25.1	24.2	26.6	28.9	13.1	16.4	8.1	20.3	15.5	13.0	13.0	20.9	13.4	12.5	17.9	20.4	17.3	16.9	17.5	14.5	18.4	15.8	22.6	10.9	14.2	17.9	26.3	23.3	16.8	15.2	17.2	8.1	16.1	13.5	24.8	15.5	21.0	14.3	16.7	16.6	15.1	28.7	14.5	23.6	16.1	14.4	20.7	14.1	19.5	13.5	12.5	24.6	15.0	13.3	13.2	9.2	12.8	11.3	4.3	6.3	15.0	11.8	9.6	22.1	18.0	14.3	10.2	14.1	16.6	23.0	11.1	21.0	12.8	17.3	12.0	17.9	23.9	22.1	7.5	25.1	9.5	12.1	23.4	26.2	26.5	11.1	34.9	16.1	34.4	14.0	14.3	10.1	9.7	0.0	22.1	11.5	14.6	15.3	3.5	23.1	7.9	11.7	16.7	9.1	17.6	17.0	7.8	4.8	11.8	21.7	20.9	10.5	8.3	25.8	18.7	12.4	7.5	16.5	15.7	5.9	5.5	13.8	11.3	15.0	16.1	24.6	10.1	23.7	11.9	13.1	12.8	13.5	13.0	13.2	12.5	9.4	13.2	11.2	7.1	13.3	15.0	6.5	13.1	9.2	22.3	27.5	26.6	28.9	20.4	17.3	15.8	22.6	16.8	14.5	20.8	16.6	13.3	10.0	27.1	20.3	12.6	5.1	29.4	19.4	7.0	23.6	18.0	28.2	13.6	81.3	20.2	17.0	0.0	13.5	17.4	11.7	18.2	25.5	10.2	15.6	28.6	10.9	11.6	23.5	129.7	13.6	19.6	13.5	10.0	13.4	21.8	19.3	14.7	10.6	16.1	37.7	25.8	16.0	94.2	31.6	25.5	35.2	20.3	10.9	20.3
SLC2A13	HMIT	ENSG00000151229	"Solute carrier family 2 member 13"	Q96QE2	12	39755021-40106089	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.7;parathyroid gland: 43.0"	"Cell type enhanced"	"Detected in many"	10	"Horizontal cells: 87.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 18.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006584, HPA061679"	Enhanced		Approved	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA006584: AB_1849755, HPA061679: "	"unprognostic (1.66e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.11e-1)"	"unprognostic (9.62e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.31e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.25e-2)"	"unprognostic (2.12e-3)"	"unprognostic (4.07e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.24e-2)"	"unprognostic (9.16e-2)"	3.8	7.2	9.8	3.3	18.0	1.2	3.0	4.0	27.7	13.0	7.4	2.8	0.3	6.0	5.9	5.3	3.7	2.9	4.0	4.9	8.2	14.1	10.7	6.2	3.7	1.9	14.9	11.0	3.1	5.0	43.0	11.1	4.6	4.8	3.0	6.8	2.4	4.2	2.6	1.2	2.1	8.3	4.7	2.7	2.3	5.6	2.0	4.1	0.6	2.2	0.9	1.4	3.9	3.9	2.0	0.1	1.5	0.5	0.6	0.9	0.0	0.6	3.6	2.6	1.2	18.5	7.7	5.3	5.8	4.1	2.6	3.4	0.0	1.7	2.2	4.3	4.6	3.6	0.3	1.8	1.8	2.2	1.9	5.4	1.7	9.1	1.3	2.9	4.9	2.9	3.8	1.7	1.2	2.2	1.5	1.2	2.2	0.7	5.7	5.9	0.6	0.7	4.1	2.9	0.0	2.5	0.0	4.0	1.2	4.8	2.2	3.3	3.4	2.3	4.5	1.5	4.1	2.5	4.3	1.1	3.5	1.3	12.4	3.4	4.5	0.1	1.4	6.4	2.8	2.2	0.0	0.5	1.5	0.4	0.2	0.3	0.1	0.4	0.9	0.0	2.0	0.2	0.5	0.8	0.6	0.1	0.1	0.1	0.0	9.8	18.0	4.0	19.8	8.2	14.1	14.9	11.0	4.8	4.1	8.9	17.1	4.7	1.7	3.7	4.3	3.5	10.2	5.3	2.3	8.7	0.0	5.0	0.0	4.3	2.5	5.2	35.1	0.0	10.9	2.1	7.1	2.7	10.3	8.5	7.2	87.4	19.5	8.0	7.9	2.1	21.3	7.4	15.1	6.4	21.3	2.0	8.7	29.4	7.1	6.4	1.3	6.5	6.1	0.9	1.9	4.5	3.1	4.4	11.1	1.4
SNUPN	"RNUT1, SNURPORTIN-1, Snurportin1"	ENSG00000169371	"Snurportin 1"	O95149	15	75598083-75626469	"Predicted intracellular proteins"	Transport	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 104.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005004	Approved		Supported	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"CAB005004: AB_425829"	"unprognostic (2.37e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.36e-2)"	"unprognostic (8.73e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.76e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.99e-3)"	"unprognostic (9.07e-2)"	"unprognostic (9.97e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.12e-1)"	"unprognostic (2.14e-2)"	17.3	17.5	18.7	13.9	21.7	11.8	22.8	16.1	26.8	20.6	17.0	16.0	21.1	13.6	25.6	20.5	14.2	23.2	19.6	17.2	18.2	17.8	19.4	20.6	15.2	17.1	18.3	21.1	26.2	15.2	17.2	14.2	14.8	19.6	16.9	16.9	17.6	18.3	26.8	29.8	15.8	15.9	23.5	14.0	18.5	15.7	31.1	13.6	25.4	23.3	17.0	19.2	16.0	21.0	17.2	20.6	5.0	17.4	14.2	29.4	17.0	11.3	15.3	14.0	9.8	19.5	21.9	10.6	11.9	17.2	20.1	21.9	11.3	28.1	21.1	16.4	15.0	16.9	13.3	27.4	16.3	15.8	12.1	24.7	25.0	14.1	7.2	18.8	17.1	17.5	20.3	16.7	15.0	18.8	18.2	18.9	16.6	15.9	13.7	20.3	3.9	16.4	16.8	18.3	18.1	8.7	21.2	10.8	20.5	17.8	6.0	12.9	8.9	5.2	17.4	29.1	17.6	14.6	31.5	12.7	16.3	15.1	8.9	10.3	9.9	18.3	31.1	17.7	26.1	21.4	3.8	17.4	5.0	21.9	16.0	26.1	15.4	22.7	20.7	20.6	17.2	29.4	24.9	3.3	14.2	16.1	20.3	17.4	17.0	18.7	21.7	16.1	26.8	18.2	17.8	18.3	21.1	19.6	13.6	11.9	12.6	9.2	9.3	11.7	15.6	11.8	15.3	13.4	11.4	8.7	11.8	24.4	46.4	19.1	104.2	9.8	12.3	0.0	16.8	31.0	18.3	8.7	12.7	14.4	22.1	12.7	15.5	15.4	19.6	35.9	29.1	20.5	18.6	21.6	11.2	17.6	14.2	14.0	27.6	22.6	18.6	19.4	6.9	40.8	14.0	9.5	10.0	13.8	15.8	5.1
SUN1	"FLJ12407, KIAA0810, UNC84A"	ENSG00000164828	"Sad1 and UNC84 domain containing 1"	O94901	7	816615-896435	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Meiosis, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Early spermatids: 286.8;Late spermatids: 435.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008346, HPA008461"	Enhanced		Enhanced	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA008346: AB_1080462, HPA008461: AB_1080461"	"unprognostic (2.70e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.57e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.57e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.69e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.47e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.34e-1)"	"unprognostic (9.33e-2)"	29.8	14.5	18.2	17.2	23.6	4.0	26.0	49.6	28.9	31.1	22.5	23.6	18.9	18.1	47.1	22.6	24.2	28.5	20.0	40.8	16.6	14.9	19.4	13.4	19.6	11.6	15.9	21.3	39.6	22.4	37.5	26.8	25.3	18.0	18.8	16.8	27.6	19.5	19.7	56.7	46.1	17.9	33.6	15.3	17.6	23.9	36.4	15.4	11.8	20.1	31.0	17.8	20.3	25.3	8.0	8.1	7.6	10.2	6.7	13.2	6.5	38.7	10.5	12.7	20.6	14.0	20.1	12.4	9.8	16.5	18.3	18.8	8.9	43.8	9.3	10.2	13.4	36.1	48.9	10.3	17.4	17.9	3.9	10.4	3.0	15.4	8.4	18.0	4.6	7.7	10.0	20.8	14.6	24.4	17.1	13.3	5.9	12.5	7.0	18.3	13.4	3.0	7.6	17.6	13.4	12.2	6.6	7.0	8.7	18.7	12.5	24.5	15.9	12.4	25.5	9.4	21.4	20.2	4.7	10.0	16.9	15.4	17.5	16.1	6.5	7.5	5.7	11.6	3.8	23.2	7.6	10.2	2.6	4.7	8.8	5.0	8.0	9.2	5.3	8.1	6.8	13.2	8.2	0.6	6.7	6.3	1.6	7.7	6.5	18.2	23.6	49.6	28.9	16.6	14.9	15.9	21.3	18.0	15.4	41.7	34.2	14.9	83.2	94.7	70.8	83.7	30.6	73.6	47.8	38.4	82.5	26.8	23.2	36.0	286.8	74.1	41.1	23.3	20.1	19.4	40.9	82.0	16.2	36.5	14.8	106.5	39.1	67.5	19.0	435.0	52.9	19.2	40.5	3.6	39.1	23.8	40.3	52.6	40.0	19.3	66.7	64.7	64.5	30.9	48.0	74.9	32.2	15.0	33.0	105.6
SUN2	UNC84B	ENSG00000100242	"Sad1 and UNC84 domain containing 2"	Q9UH99	22	38734725-38794143	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Meiosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"T-cells: 112.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001209	Supported		Supported	"Nuclear membrane"		NA	Yes			"Nuclear membrane"		"HPA001209: AB_1080465"	"unprognostic (9.76e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.32e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.94e-2)"	"unprognostic (2.37e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.25e-3)"	"unprognostic (8.15e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.33e-2)"	59.3	22.9	28.7	41.7	58.7	84.6	66.9	17.6	43.8	33.7	33.6	57.5	24.2	29.0	47.3	23.3	41.4	42.5	25.3	32.3	37.8	19.3	24.4	47.1	37.7	56.8	73.6	25.4	44.8	44.1	10.5	14.8	22.7	42.5	31.2	16.3	14.9	39.1	35.0	48.6	31.0	31.6	35.3	37.1	46.3	35.2	30.2	68.0	42.6	26.9	20.1	36.0	47.0	35.9	6.4	6.0	14.0	13.9	13.3	25.5	11.8	25.1	11.7	11.7	13.0	35.7	8.9	15.3	17.3	20.3	20.6	17.5	10.5	28.5	7.9	21.2	24.5	12.7	18.8	3.9	12.8	8.5	27.5	15.8	5.1	12.6	9.4	21.7	17.4	54.3	7.5	10.9	9.8	9.2	13.9	16.3	16.0	6.5	45.0	11.1	8.0	9.6	15.1	1.1	17.8	7.6	16.1	16.4	23.8	5.1	12.3	10.4	3.8	19.3	21.5	10.1	5.7	14.4	32.7	27.3	15.0	13.1	13.1	22.4	33.3	10.4	8.4	27.8	21.0	25.0	14.0	7.4	9.7	25.5	8.8	16.5	6.3	16.2	20.6	6.0	6.4	17.1	20.1	8.0	13.3	13.9	3.7	11.0	11.8	28.7	58.7	17.6	43.8	37.8	19.3	73.6	25.4	42.5	68.0	20.8	22.2	33.6	23.8	16.1	8.4	2.2	35.7	2.7	17.0	31.4	7.9	11.6	3.3	30.6	1.7	29.2	45.1	23.3	41.2	49.9	28.2	22.7	25.3	93.6	23.5	20.6	17.9	30.1	39.8	2.0	56.7	37.5	16.9	3.6	25.6	21.7	45.2	31.3	61.5	16.3	12.4	51.8	34.0	0.9	0.7	15.1	12.4	112.3	17.8	18.0
SYNE3	"C14orf139, C14orf49, FLJ25605, LINC00341, NCRNA00341, Nesp3, Nesprin-3, NET53"	ENSG00000176438	"Spectrin repeat containing nuclear envelope family member 3"	Q6ZMZ3	14	95407266-95475836	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 12.2;bone marrow: 10.0"	"Cell type enhanced"	"Detected in many"	13	"Cardiomyocytes: 43.7;Cone photoreceptor cells: 58.9;Rod photoreceptor cells: 109.0"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 25.2;ASC TERT1: 19.8;Karpas-707: 22.3;REH: 17.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA055227, HPA077140"	Approved		Supported	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA055227: AB_2682747, HPA077140: AB_2686826"	"unprognostic (4.63e-2)"	"unprognostic (6.99e-3)"	"unprognostic (3.79e-1)"	"unprognostic (1.48e-3)"	"unprognostic (7.15e-2)"	"unprognostic (2.12e-3)"	"unprognostic (2.45e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.92e-1)"	"unprognostic (2.87e-1)"	"unprognostic (8.50e-2)"	"unprognostic (3.32e-1)"	"unprognostic (7.41e-6)"	"unprognostic (1.31e-1)"	"unprognostic (1.42e-1)"	"unprognostic (6.95e-2)"	"unprognostic (7.19e-2)"	12.2	2.4	1.2	2.7	1.3	10.0	6.5	0.3	1.2	2.1	1.0			0.6	1.2	0.6	1.1	2.0	1.2	2.8	1.6	1.1	0.4	1.0	2.7	4.0	1.6		3.0	0.1	0.0	0.5	2.1		0.6	1.6		1.9	0.4	1.1	2.8	1.5	1.2	2.6	2.7	0.9	1.6			1.7		4.3	1.6	2.8	3.4	2.6	5.4	5.1	0.9	3.7	2.2	0.6	0.1	0.3	0.5	25.2	19.8	7.6	2.8	4.9	2.7	2.1	4.0	0.7	3.2	0.5	1.3	0.8	0.1	0.6	2.1	1.2	10.6	0.4	2.2	0.5	1.1	3.3	3.3	5.5	5.5	0.7	3.4	2.0	0.2	4.7	1.0	0.1	22.3	2.0	0.7	1.9	3.7	0.1	0.1	1.3	17.6	12.3	6.8	0.3	0.3	0.5	2.7	0.1	0.0	1.3	0.3	1.1	4.9	4.2	2.0	1.2	2.6	0.3	2.7	5.4	3.0	3.9	7.5	14.7	5.4	5.1	0.4	2.2	4.0	2.8	3.4	2.9	2.3	2.1	3.3	3.7	3.0	2.4	0.9	4.1	2.6	2.3	2.2											8.9	19.4	15.7	0.2	2.1	4.2	43.7	0.0	12.0	1.2	0.0	58.9	1.4	0.0	0.0	2.9	11.7	2.1	0.0	0.3	13.8	7.1	0.8	11.5	4.5	3.9	6.4	1.2	3.1	18.0	1.5	12.0	13.3	5.0	1.0	4.1	5.2	0.5	5.8	0.4	0.3	109.0	6.5	9.2	0.5	0.9	0.9	1.6	8.5	1.6	0.2
TMEM221		ENSG00000188051	"Transmembrane protein 221"	A6NGB7	19	17435509-17448567	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 11.4"	"Group enriched"	"Detected in some"	11	"Cone photoreceptor cells: 13.7;Muller glia cells: 51.3;Rod photoreceptor cells: 22.4"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 3.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 7.4;PC-3: 11.3;REH: 6.3"									"HPA041580, HPA062945"	Supported		Approved	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA041580: AB_10795700, HPA062945: "	"unprognostic (3.60e-2)"	"unprognostic (7.86e-2)"	"unprognostic (4.51e-4)"	"unprognostic (2.09e-2)"	"unprognostic (2.61e-2)"	"unprognostic (9.14e-3)"	"unprognostic (3.19e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.72e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.47e-4)"	"unprognostic (2.37e-2)"	"unprognostic (6.67e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.23e-1)"	1.0	6.1	5.4	0.7	2.9	0.5	1.6	1.3	7.0	0.9	0.8	1.1	0.0	0.4	1.2	3.1	0.9	6.2	1.5	1.2	6.0	2.1	0.7	0.4	0.7	0.6	1.2	2.5	11.4	5.4	10.2	2.5	0.5	3.3	3.8	0.4	6.5	3.3	4.6	0.6	1.2	0.6	0.6	3.1	0.5	0.6	2.4	1.8	0.0	1.4	1.1	0.4	0.9	3.3	0.0	1.6	0.0	0.1	0.0	0.7	0.1	0.8	2.5	1.0	7.4	0.0	0.0	0.2	0.3	0.0	0.1	0.4	0.1	0.2	0.2	1.5	0.0	0.6	0.3	2.2	0.1	0.0	0.1	1.9	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.7	0.0	0.5	0.1	0.1	0.0	0.1	0.2	0.3	1.6	0.6	11.3	6.3	0.2	0.0	0.5	0.5	0.1	0.3	0.0	0.0	0.1	0.7	0.3	0.3	0.1	0.1	0.2	0.3	0.1	0.5	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.1	0.7	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.6	0.0	0.1	5.4	2.9	1.3	7.0	6.0	2.1	1.2	2.5	3.3	1.8	0.0	0.3	0.0	0.1	0.0	0.9	0.3	2.5	0.0	0.0	0.0	13.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.8	1.6	0.0	1.8	0.0	0.0	1.1	0.0	0.0	0.0	0.0	51.3	0.1	0.0	1.1	0.0	22.4	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.1
TMEM47	"BCMP1, DKFZp564E153, DKFZP761J17121, TM4SF10, VAB-9"	ENSG00000147027	"Transmembrane protein 47"	Q9BQJ4	X	34627064-34657288	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Leydig cells: 68.7;Muller glia cells: 146.8;Peritubular cells: 87.4;Sertoli cells: 90.5;Smooth muscle cells: 67.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 27.5;fHDF/TERT166: 84.5;RPTEC TERT1: 20.8;U-2197: 18.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046658	Approved		Approved	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA046658: AB_2679742"	"unprognostic (1.50e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.82e-2)"	"unprognostic (6.74e-3)"	"unprognostic (7.29e-2)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (1.67e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.36e-1)"	"prognostic favorable (4.05e-6)"	"unprognostic (2.69e-2)"	"unprognostic (7.19e-2)"	"unprognostic (2.76e-1)"	"unprognostic (9.94e-2)"	19.7	11.3	22.3	4.3	28.3	0.0	19.0	8.1	18.5	26.7	13.7	15.0	7.6	4.5	24.8	18.7	19.2	19.5	15.4	18.4	24.1	17.2	15.0	12.8	11.7	2.9	10.5	9.5	15.3	5.9	2.0	4.5	0.6	14.0	18.4	8.1	19.0	17.1	26.0	11.8	3.6	6.3	29.9	6.9	3.7	8.5	7.0	15.7	0.3	10.9	4.8	2.1	21.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	12.6	5.3	11.2	8.5	0.0	27.5	0.0	5.4	4.7	0.0	0.0	0.0	2.3	84.5	0.0	0.0	3.5	0.9	8.1	0.0	2.4	0.0	3.5	0.0	6.4	0.0	0.0	7.6	0.0	2.2	2.4	9.8	6.1	0.0	0.0	0.0	10.2	0.2	0.0	0.0	1.5	0.1	0.0	0.0	6.3	0.0	20.8	8.0	0.1	0.0	0.0	0.3	0.0	1.4	0.0	0.0	0.2	11.1	1.1	18.5	1.1	0.0	0.0	0.0	4.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.3	28.3	8.1	12.4	24.1	17.2	10.5	9.5	14.0	15.7	17.9	1.1	0.0	11.6	7.2	6.6	24.4	10.2	1.4	2.3	15.7	5.9	0.0	6.6	0.8	0.4	30.5	0.0	0.0	4.4	0.1	42.9	11.2	2.3	12.9	0.1	28.6	0.0	39.3	0.6	1.1	68.7	2.1	62.4	0.0	0.0	146.8	3.3	0.0	87.4	11.5	6.1	90.5	67.4	0.3	1.9	4.5	0.1	0.0	0.0	10.9
TMPO	"LAP2, LEMD4, TP"	ENSG00000120802	Thymopoietin	"P42166, P42167"	12	98515512-98550379	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		DNA-binding	Cardiomyopathy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 130.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008150, CAB009847, HPA070805"	Enhanced		Enhanced	"Nuclear membrane"		NA	Yes			"Nuclear membrane"		"CAB009847: AB_2205450, HPA008150: AB_1079235, HPA070805: "	"unprognostic (2.36e-1)"	"unprognostic (4.46e-3)"	"unprognostic (5.90e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.74e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.67e-3)"	"prognostic unfavorable (9.34e-4)"	"unprognostic (6.01e-3)"	"unprognostic (2.85e-1)"	"unprognostic (5.26e-2)"	"unprognostic (3.26e-2)"	10.8	9.5	8.1	25.0	9.5	36.8	12.7	19.1	11.0	16.9	22.9	10.7	8.7	15.9	18.4	17.1	23.0	15.4	10.3	9.6	8.5	8.3	15.8	20.5	13.8	34.0	9.0	11.2	34.7	21.6	9.9	9.9	13.6	7.6	15.6	17.6	12.5	14.0	9.7	9.4	11.7	22.6	10.7	9.4	29.1	16.8	11.4	10.3	130.9	13.2	12.2	35.4	13.0	17.9	14.1	10.9	18.1	33.1	9.7	15.6	13.3	30.8	20.4	50.3	25.5	4.2	5.6	29.8	25.4	13.5	34.5	25.1	22.2	15.5	53.9	15.6	14.7	12.6	19.8	42.1	19.1	31.7	37.7	26.1	46.1	18.6	14.6	3.8	53.2	30.8	3.1	6.3	20.3	10.9	12.0	19.6	33.6	38.9	20.9	21.4	19.4	86.8	42.0	30.2	28.6	19.1	72.9	33.3	37.3	12.2	28.8	39.8	23.8	43.5	27.3	13.7	20.6	30.8	25.6	10.5	20.0	17.5	13.6	25.9	22.8	38.8	60.3	5.7	30.9	26.5	18.1	14.4	6.1	9.5	25.0	10.2	10.9	11.1	10.8	10.9	14.1	15.6	11.7	1.1	9.7	33.1	6.1	13.3	13.3	8.1	9.5	19.1	11.0	8.5	8.3	9.0	11.2	7.6	10.3	29.8	18.0	45.4	21.4	24.6	20.8	7.1	25.5	36.1	48.9	29.6	11.8	16.5	26.6	16.3	26.8	36.0	27.6	70.0	27.6	75.5	19.0	17.7	27.8	45.0	32.2	9.5	27.5	32.5	64.7	21.9	26.4	40.1	16.9	34.3	51.4	24.2	21.6	31.5	38.2	27.8	47.9	19.4	15.6	38.6	53.5	20.5	9.8	33.1	42.9	16.3
TMX4	"DJ971N18.2, KIAA1162, PDIA14, TXNDC13"	ENSG00000125827	"Thioredoxin related transmembrane protein 4"	Q9H1E5	20	7977348-8019829	"Predicted membrane proteins"	"Electron transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 607.5;Late spermatids: 1164.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000399, HPA015752"	Enhanced		Approved	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA000399: AB_1858471, HPA015752: AB_1858470"	"unprognostic (3.93e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.18e-3)"	"unprognostic (5.14e-2)"	"unprognostic (8.64e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.96e-1)"	"unprognostic (5.80e-3)"	"unprognostic (3.16e-1)"	"prognostic favorable (2.60e-5)"	"unprognostic (1.34e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.55e-1)"	"unprognostic (7.06e-2)"	11.2	24.6	15.4	10.6	20.8	15.7	12.2	19.9	30.5	27.5	17.6	11.7	34.2	8.0	18.0	21.6	10.0	18.6	13.3	35.0	15.5	30.9	18.5	17.3	11.6	14.7	15.6	16.2	23.0	11.0	23.9	40.9	7.6	21.8	16.7	8.2	14.7	24.2	31.4	21.7	6.5	10.2	19.2	10.7	9.9	13.7	48.2	7.2	8.5	16.3	8.8	8.7	14.8	11.2	10.1	9.9	51.2	8.0	11.5	17.8	13.5	4.2	6.4	6.4	7.2	14.3	15.9	1.9	11.1	15.4	7.1	5.1	4.3	10.7	11.5	8.8	11.1	10.4	3.9	4.6	6.8	7.4	5.8	5.1	5.7	2.8	7.0	13.5	21.0	8.5	9.6	8.7	6.1	14.4	17.1	8.1	8.7	7.0	29.6	7.8	2.9	0.6	13.2	5.1	6.5	7.1	6.6	22.9	12.0	10.1	2.5	12.8	15.7	18.4	0.8	10.9	4.2	7.8	10.3	10.7	19.1	5.3	7.1	10.8	29.9	8.3	23.1	9.2	10.5	13.3	22.6	8.0	23.3	12.2	4.7	12.0	10.1	12.5	17.8	9.9	8.1	7.6	10.2	51.2	11.5	5.0	3.3	15.9	13.5	15.4	20.8	19.9	30.5	15.5	30.9	15.6	16.2	21.8	7.2	32.8	26.9	44.7	51.6	14.5	52.6	198.1	50.9	28.1	23.9	55.8	55.0	16.8	18.3	23.8	607.5	41.3	21.6	0.0	28.7	5.3	46.6	47.3	59.9	47.0	23.0	87.4	53.6	33.7	36.0	1164.8	71.4	37.5	43.9	7.2	21.4	79.0	22.5	19.8	52.6	20.7	90.7	32.3	28.1	158.4	45.1	13.7	6.9	66.0	23.9	26.3
TOR1AIP1	"FLJ13142, LAP1B"	ENSG00000143337	"Torsin 1A interacting protein 1"	Q5JTV8	1	179882042-179925000	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 252.7;Late spermatids: 162.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047151, HPA050546, HPA070991"	Enhanced		Enhanced	"Nuclear membrane"		NA	NA		17000	"Nuclear membrane"		"HPA047151: AB_2679956, HPA050546: AB_2681167, HPA070991: "	"unprognostic (1.41e-1)"	"unprognostic (3.95e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.37e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.00e-2)"	"unprognostic (6.33e-2)"	"unprognostic (7.04e-2)"	"unprognostic (8.62e-2)"	"unprognostic (1.93e-1)"	"unprognostic (9.10e-2)"	"unprognostic (4.40e-2)"	"unprognostic (4.41e-2)"	"unprognostic (2.87e-1)"	"unprognostic (7.75e-2)"	"unprognostic (4.02e-2)"	29.3	26.4	27.1	25.1	28.1	52.2	25.4	28.6	30.5	33.2	40.0	24.6	38.2	11.6	33.6	33.0	30.1	27.6	27.2	29.3	28.3	20.8	27.2	27.1	25.5	28.2	31.7	23.6	42.5	24.6	31.1	30.5	20.3	27.3	33.6	17.0	27.0	21.9	42.9	44.7	17.8	21.6	46.9	26.1	27.8	30.9	23.5	32.2	24.9	34.5	28.8	21.8	40.7	30.5	19.0	27.9	61.0	35.9	21.4	29.4	29.9	13.2	13.3	9.2	11.8	41.8	28.1	17.8	18.0	21.4	16.9	17.4	10.4	25.1	3.4	20.0	18.3	11.9	23.3	8.6	14.4	19.8	22.5	8.7	9.5	12.6	10.1	19.2	32.0	29.4	22.6	11.3	20.6	19.4	18.9	15.0	14.5	13.7	17.6	17.6	11.8	13.1	10.0	13.2	17.2	5.2	8.1	14.5	9.1	16.3	25.9	7.9	10.9	22.2	21.4	29.9	14.3	16.7	33.1	15.4	23.8	10.0	15.6	21.0	20.0	26.1	7.0	8.9	17.8	35.8	45.8	26.4	61.0	24.9	29.1	29.4	17.7	23.0	24.9	27.9	19.0	23.8	24.4	41.0	21.4	35.9	20.2	24.2	29.9	27.1	28.1	28.6	30.5	28.3	20.8	31.7	23.6	27.3	32.2	29.8	29.7	21.3	56.6	38.5	11.5	22.2	17.8	25.4	25.0	19.2	15.7	14.9	11.6	16.7	252.7	29.5	10.5	0.0	21.9	20.2	28.2	41.1	34.7	27.6	24.0	6.4	19.4	31.9	46.0	162.0	44.0	27.6	13.5	20.8	9.9	36.5	21.9	11.5	55.2	15.6	12.9	25.8	37.5	11.2	19.5	32.9	15.2	37.1	8.1	46.4
TPR		ENSG00000047410	"Translocated promoter region, nuclear basket protein"	P12270	1	186311652-186375693	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis, mRNA transport, Protein transport, Translocation, Transport"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Spermatocytes: 640.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019661, HPA019663, HPA024336"	Enhanced		Enhanced	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA019661: AB_1858215, HPA019663: AB_1858216, HPA024336: AB_1858217"	"unprognostic (4.51e-2)"	"unprognostic (9.87e-3)"	"unprognostic (2.48e-1)"	"unprognostic (7.56e-2)"	"unprognostic (9.88e-3)"	"prognostic favorable (4.71e-4)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (1.71e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.31e-3)"	"unprognostic (3.75e-1)"	"unprognostic (4.19e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.98e-2)"	21.5	17.3	14.3	26.7	21.3	21.6	19.0	24.4	17.1	21.7	24.2	7.3	27.1	12.9	20.8	23.5	18.5	16.9	16.8	28.3	13.8	10.5	18.7	20.6	17.9	20.4	14.1	16.6	24.7	17.8	44.2	29.1	29.7	15.1	22.2	17.7	9.1	20.2	30.1	33.1	20.5	21.1	21.2	16.4	26.1	18.8	35.0	17.8	39.5	21.7	19.7	21.4	25.1	19.1	19.1	19.8	50.3	15.2	10.7	16.9	5.2	21.6	18.7	28.1	16.3	22.6	20.2	29.6	24.9	16.7	17.6	16.4	28.2	18.5	25.4	19.3	16.9	12.1	28.4	21.1	17.0	21.8	19.0	23.1	33.8	30.3	19.7	12.1	36.0	22.2	15.4	10.3	26.5	20.6	16.3	20.7	14.6	40.7	22.9	18.7	18.7	17.9	9.6	30.9	19.8	6.5	21.2	22.0	22.0	14.4	26.1	15.3	24.3	29.0	19.3	15.6	40.1	21.4	23.0	29.1	17.6	16.8	19.4	30.1	25.1	29.3	23.2	11.3	18.4	15.7	29.5	12.0	21.9	15.8	10.0	13.3	15.2	13.8	12.7	6.8	19.1	16.9	11.7	50.3	10.7	15.2	19.8	15.3	5.2	14.3	21.3	24.4	17.1	13.8	10.5	14.1	16.6	15.1	17.8	202.5	98.3	78.9	89.1	89.9	87.4	160.6	35.7	133.8	120.6	55.8	74.6	117.3	19.9	88.2	106.7	100.9	41.3	23.3	65.3	89.1	87.0	62.9	77.5	34.3	63.0	93.8	65.1	57.1	60.2	23.6	116.2	74.5	52.3	147.9	49.2	93.4	74.7	52.6	110.3	23.7	104.0	129.4	82.9	640.0	239.5	86.7	126.1	97.0	64.6	75.6
ZCCHC14	"BDG29, MGC14139"	ENSG00000140948	"Zinc finger CCHC-type containing 14"	Q8WYQ9	16	87406246-87492045	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 48.6"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014122			Uncertain	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA014122: "	"unprognostic (2.04e-2)"	"unprognostic (2.84e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.67e-1)"	"unprognostic (3.99e-1)"	"unprognostic (6.74e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.46e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.88e-2)"	"prognostic favorable (1.47e-14)"	"unprognostic (1.06e-1)"	"unprognostic (1.81e-1)"	"unprognostic (7.13e-2)"	"unprognostic (2.83e-2)"	4.9	5.3	3.3	2.2	3.7	0.6	3.9	9.3	4.5	5.2	3.6			6.3	5.0	2.9	3.5	4.0	4.6	4.2	3.1	2.5	4.6	9.0	4.0	1.6	2.1		7.8	5.7	8.5	4.2	3.1		2.6	3.5		3.3	3.3	3.4	5.4	6.3	3.4	1.8	1.8	3.6	16.8			5.3		1.3	4.2	3.7	0.3	0.3	0.8	1.8	1.0	2.6	0.3	6.9	5.2	8.6	11.3	11.5	7.8	5.2	3.5	5.0	4.2	2.1	11.3	6.0	3.8	4.7	6.7	10.6	11.3	8.1	2.7	5.4	1.1	10.5	3.7	7.6	11.0	5.0	0.9	1.9	6.8	5.6	8.0	5.0	6.3	5.8	2.2	8.7	1.1	3.7	7.6	0.1	4.6	6.4	4.2	4.8	9.8	4.7	1.6	7.6	3.9	19.5	24.7	25.7	3.5	14.2	5.6	8.4	8.1	4.7	10.4	7.8	9.4	5.8	2.4	1.3	11.4	4.6	6.0	6.7	0.0	0.4	0.3	1.1	0.1	2.6	0.3	1.1	1.7	0.3	0.3	2.0	1.0	0.8	1.0	1.8	0.2	1.8	0.3											11.9	9.8	1.9	2.2	16.3	20.0	8.1	15.3	12.0	18.2	5.2	5.9	2.8	3.3	6.4	19.8	11.2	16.3	0.0	7.0	1.6	8.8	2.9	1.1	26.4	4.7	22.3	20.2	14.1	8.1	31.5	10.3	5.6	6.8	0.0	15.8	7.5	7.3	5.8	9.6	8.4	14.8	19.4	26.4	48.6	19.0	15.3	3.1	4.3	14.2	2.0
ZNF665	FLJ14345	ENSG00000197497	"Zinc finger protein 665"	Q9H7R5	19	53159213-53193386	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 17.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA023437	Uncertain		Approved	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA023437: AB_2671205"	"unprognostic (8.01e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.04e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.63e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.27e-2)"	"unprognostic (5.81e-4)"	"unprognostic (2.26e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.45e-1)"	"unprognostic (9.27e-2)"	4.3	3.8	4.2	4.3	6.7	2.3	5.1	10.7	6.2	5.3	4.0	5.7	2.6	1.6	6.4	5.2	3.2	6.7	2.9	2.6	5.2	2.6	2.6	1.1	3.6	4.2	5.5	3.2	11.5	2.7	7.7	4.8	2.9	4.8	6.0	2.6	6.0	2.9	4.0	1.4	3.3	2.6	5.5	6.5	3.9	2.9	3.4	7.0	7.2	5.8	1.5	3.2	5.4	4.1	5.4	1.6	1.5	1.1	4.9	2.2	0.5	1.1	0.2	1.2	3.8	1.2	2.2	2.8	2.8	1.7	2.7	3.8	0.5	1.0	2.0	2.0	2.0	1.8	0.4	0.7	0.2	4.4	0.0	0.1	0.1	0.7	0.1	2.7	0.5	1.0	2.6	0.0	2.4	0.0	0.8	0.2	0.1	0.4	0.6	0.1	0.4	5.4	1.6	2.2	0.0	0.6	0.1	0.1	0.8	0.5	5.3	0.5	2.4	0.2	0.4	0.1	2.8	1.5	1.1	0.7	1.8	2.2	1.7	1.0	0.3	4.6	4.9	0.1	1.4	2.6	1.5	0.5	1.1	0.8	0.3	1.0	2.7	1.0	2.2	0.9	5.4	1.8	1.9	1.4	4.9	1.1	1.6	0.7	0.5	4.2	6.7	10.7	6.2	5.2	2.6	5.5	3.2	4.8	7.0	17.9	9.6	1.7	2.9	1.0	5.7	0.8	2.5	8.1	6.8	5.2	0.0	2.0	3.3	1.1	1.5	2.5	0.3	0.0	0.6	2.1	1.9	2.1	4.7	0.4	1.1	11.1	2.4	1.8	1.0	0.8	2.0	1.1	1.7	2.8	0.3	6.8	0.4	0.0	2.8	0.3	3.7	0.0	2.1	1.9	7.0	0.5	0.7	3.8	0.7	2.0
